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1 Introduction 
Epoxides are versatile intermediates in organic synthesis. Enantiopure 
epoxides are of greater interest because they can serve as high-value 
synthons in the production of chiral pharmaceuticals and agrochemicals. 
Fig. 1. Epoxidation 
reactions found in 
microorganisms. 
(a) Monooxygenases. 
(b) peroxidases, and 
(c) halohydrin 
epoxidases. 
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Several review articles describe both the chemical and the biological 
production of enantiopure epoxides (De Bont, 1992, Leak et al„ 1993, 
Besse & Veschambre, 1994). The biological research initially focused on 
the direct epoxidation of alkenes by several types of monooxygenases, or 
on the use of other enzyme systems like peroxidases, and halohydrin 
epoxidases (Fig. 1). More recently, enantioselective resolution of epoxides 
has attracted attention (Chapter 2 of this thesis). Sofar two types of 
enantioselective degradation by microorganisms have been investigated in 
more detail, the epoxide hydrolase found in several microorganisms and 
the enantioselective degradation of 2,3-epoxyalkanes found in 
Xanthobacter Py2. The enzymes involved in this latter type of 
enantioselective resolution are described in this thesis 
Chapter 1 
Chapter 2 of this thesis presents an overview on the various types of 
epoxide degradation enzyme systems found in microorganisms to show 
the diversity of epoxide conversion. 
The isolation and characterization of mutants of Xanthobacter Py2 not 
able to degrade epoxyalkanes, the (sub)cloning and restriction analysis of 
DNA fragments complementing this mutation and the heterologous 
expression is described in Chapter 3. Four open reading frames (ORFs) 
were found on the DNA fragment complementing a Xanthobacter Py2 
mutant. 
In Chapter 4 the involvement of one of these ORFs, the ORF3 protein in 
epoxyalkane degradation, is demonstrated. The amino acid sequence of 
this protein is analyzed and its relation with pyridine nucleotide-disulfide 
oxidoreductases is established. Furthermore, this chapter deals with the 
cofactors involved in the degradation of epoxyalkanes in crude extract. 
Chapter 5 describes the purification and characterization of the ORF3 
protein. The involvement of this protein in the degradation of 
epoxyalkanes in Xanthobacter Py2 is discussed. 
Finally, Chapter 6 is of a speculative nature. Based on the information 
available, a mechanism is postulated to describe the degradation of 
epoxyalkanes in Xanthobacter Py2. 
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2 Microbial transformation of epoxides 
Enzyme & Microbial 
Technology (1998), 
22, 19-26 
Jelto Swaving and Jan A.M. de Bont 
Enantioselective degradation of racemic epoxides is an 
interesting method to obtain optically pure epoxides. In this 
review, an overview is presented on the bioconversion of 
epoxides in microorganisms. Both the degradation and 
biosynthesis routes involving epoxides are discussed as well as 
their usefulness in enantioselective degradation. 
Introduction 
In recent years, the production of optically pure epoxides has received 
considerable attention because these compounds are valuable synthons in 
organic synthesis. As discussed in recent reviews (Leak et al., 1992, De 
Bont, 1993, & Besse & Verschambre, 1994), biotechnological research 
initially focused on direct epoxidation of alkenes by action of 
monooxygenases. More recently, however, the enantioselective 
degradation of racemic mixtures of epoxides has been studied in more 
detail. This method for the production of optically pure epoxides suffers 
from the disadvantage that at least 50% of the substrate is not converted 
into product. But the method may find applications in obtaining optically 
pure epoxides because racemic mixtures of epoxides are cheaply prepared. 
Furthermore, the resulting degradative product may be an optically pure 
compound of interest for further applications. As a consequence, the 
interest in microbial epoxide degradation has increased. Several groups 
are now engaged in research on more fundamental aspects of epoxide 
degradation. In view of this development, the transformation of epoxides 
in microbial systems is reviewed. Distinct systems for epoxide conversion 
will be shown. 
We first will touch on epoxides as intermediates in organic synthesis, and 
then epoxides degrading enzymes will be discussed by grouping them into 
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(i) enzymes having a detoxifying function, (ii) enzymes playing a role in 
biosynthetic routes, and (iii) enzymes involved in the conversion of 
epoxides as intermediates in degradation pathways. 
EPOXIDES IN ORGANIC SYNTHESIS 
Due to their electronic polarization and the strain of the three-ring 
structure, epoxides are highly reactive molecules that react readily with a 
number of reagents in particular nucleophiles. Commonly used 
nucleophiles reacting with epoxides are oxygen, nitrogen, sulfur, halide, 
and carbon compounds. The direction in which unsymmetrical epoxides 
can be opened depends on the reaction conditions used. A nucleophilic 
base will attack on the less hindered epoxide carbon. If, however, an acid 
is used predominantly, the more substituted carbon is attacked. Because of 
these properties, epoxides are very versatile intermediates in organic 
synthesis. 
Optically pure epoxides are attracting more and more attention as high-
value chiral intermediates especially in the synthesis of bioactive 
compounds. In a review by Furahashi (1986) the microbial production and 
use of different kinds of optically pure epoxides has been described. 
Among the optically pure epoxides produced by Nocardia corallina B-
276 are aryl glycidyl ethers used for the synthesis of p-blokkers and the 
chiral part of ferroelectric liquid crystals. Some more recent examples on 
the use of optical pure epoxides in the production of chiral (bioactive) 
compounds are, e.g., leukotrienes (Neumann & Colson, 1991, Bellamy et 
al., 1992), insect pheromones (Millar et al, 1990, Rollin & Klaffe, 1991) 
steroids (Joannou & Reeder, 1996, Scherlitz Hoffmann et al., 1996) and 
antibiotic compounds (Evans et al., 1991, Gala & Dibenedetto, 1994) such 
as HIV protease inhibitors (Ng et al., 1995). For this latter compound, an 
interesting example on the strength of enantioselective degradation of 
epoxides using microbial systems has been published recently. The 
optically pure intermediate of the HIV protease inhibitor 1(S), 2(R) indene 
oxide could be prepared with an e.e. of 100% from a racemic mixture 
using a fungal epoxide hydrolase (Zhang et al., 1995). 
Detoxification of epoxides 
Epoxides are generally formed from olefinic and aromatic compounds 
using (cytochrome P-450) monooxygenases. The highly reactive epoxides 
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react readily with a great number of compounds including cell compounds 
such as proteins and DNA. It is therefore important for organisms to 
immediately eliminate these compounds, e.g., by direct attack on the 
epoxide group. Two types of enzymes have been described for the 
detoxification of epoxides: (i) glutathione transferases as a class of general 
detoxifying enzymes and (ii) epoxide hydrolases that are specific for the 
detoxification of epoxides. 
Glutathione transferase 
Glutathione transferases (GST) are found in most aerobic eukaryotes and 
prokaryotes. They protect cells against chemically induced toxicity by 
catalyzing the S-conjugation between the thiol group of glutathione and 
the electrophilic moiety of the (toxic) substrate (Fig. la). GSTs have been 
studied most extensively in mammalian systems (Armstrong, 1987, Dirr et 
al, 1994) where five different classes of mammalian GSTs have been 
found. Four classes are soluble forms, named according to their primary 
structure and subunit composition (Mannervik et al., 1992), and the fifth 
class is a microsomal form (DeJong et al., 1988). 3D structures of several 
soluble GSTs are known and have been reviewed (Dirr et al., 1994). The 
data obtained from these 3D structures suggest that in the active site, the 
thiol group of the glutathione is destabilized, thereby enhancing the 
nucleophilic reactivity. Furthermore, evidence suggests that the oxygen of 
the epoxide group forms a hydrogen bond with the hydroxyl group of a 
tyrosine present in the active site, thus facilitating the addition of GS" to 
the carbon of the oxiran ring (Johnson et al., 1993, Ji et al., 1994). 
GSTs are widely spread in fungi and yeast (Ando et al., 1988, Kumagi et 
al, 1988, Tamaki et al, 1989, Datta & Samanta, 1992) as well as in 
bacteria (Di Ilio et al, 1988, Iizuka et al, 1989, Piccolomini et al, 1989, 
Area et al., 1990, Di Ilio et al, 1993, Orser et al, 1993, Zablotowicz et 
al, 1995). The size and composition of the GST proteins found in 
microorganisms resemble the mammalian GSTs in being dimers with 
molecular weights of approximately 50 kDa. The few amino acid 
sequences known from bacterial (LaRoche & Leisinger, 1990, Orser et al., 
1993, Mignogna et al, 1993) and yeast (Tamaki et al, 1991) GSTs show 
little homology with the mammalian sequences or each other. Antigenic 
characterization (Piccolomini et al., 1989, Di Dio et al, 1991) as well as 
the substrate specificity studies of the purified GSTs indicate that there are 
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a large number of different GSTs. Only few bacterial GSTs have been 
reported to degrade the model epoxide compound l,2-(p-nitrophenoxy)-
propane (Di Dio et al., 1988, Di Dio et al., 1993). The activity of these 
GSTs toward this compound is very low. Other examples of GSTs 
involved in epoxide conversion are reported by Area et al. (1990), where a 
GST from Escherichia coli is involved in epoxide fosfomycin conversion, 
and by Van Hylckama Vlieg et al. (1996), where a GST from a 
Rhodococcus sp. degrades a range of epoxides; e.g., isoprene monoxide 
and aliphatic epoxides. To our knowledge, no reports on the degradation 
of epoxides by fungal or yeast GSTs have been published. 
At present, very limited information on the stereoselectivity of epoxide 
degradation by GSTs is available. The mammalian Class Mu GST 
isoenzyme 4-4 is very selective toward phenantrene 9,10-oxide (Zhang et 
al., 1992). This shows that, in theory, this enzyme can be used for the 
production of optically pure epoxides. A distinct disadvantage of any 
GST-catalyzed reaction in the production of optically pure epoxides is the 
requirement for glutathione or possibly another sulfhydryl compound as 
reactant. This requirement may, in principle, make the use of GSTs more 
costly than the use of epoxide hydrolases. 
Epoxide hydrolase 
Another example of an enzyme involved in detoxification reactions in 
mammals is the epoxide hydrolase, but contrary to the glutathione 
transferases, epoxide-hydrating enzymes have more functions in 
biological systems. They are involved in several degradation pathways 
and in the biosynthesis of biologically important compounds. In 
mammals, two kinds of epoxide hydrolases have been described - the 
microsomal and the soluble epoxide hydrolases. These enzymes have been 
purified and are well characterized. In several instances, their nucleotide 
sequences have been determined (Beetham et al., 1995). 
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Fig. 1. Detoxification 
of epoxides by 
(a) glutathione 
transferases and 
(b) epoxide 
hydrolases including 
the covalent 
hydroxyacyl 
intermediate. 
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Both types of epoxide hydrolases show evolutionary relationships with 
each other and with other hydrolases (Arand et al., 1994, Koonin & 
Tatusov, 1994, Beetham et al., 1995). By analogy to the haloalkane 
dehalogenase of Xanthobacter autotrophicus GJ10, a putative catalytic 
scheme for epoxide hydrolases is thought to involve a hydroxyacyl 
enzyme intermediate (Arand et al., 1994, Hammock et al., 1994, Borhan 
et al, 1995, Beetham et al, 1995, Arand et al, 1996) (Fig. lb). The 
amino acids involved in the reaction have been identified (Arand et al., 
1996). 
Recently, epoxide hydrolases from microorganisms have received 
considerable attention for use in biotransformations. The stereoselective 
transformation of epoxides by epoxide hydrolases is very interesting for a 
number of reasons. Firstly, no cofactors are involved. Secondly, the 
epoxide hydrolases studied sofar have broad substrate specificity. 
Furthermore, both the remaining optically pure epoxide and the optically 
pure diol product can be used as synthons in asymmetric synthesis. 
The first examples of microbial epoxide hydrolases found in the literature 
describe a Flavobacterium (Martin & Foster, 1955) and a Pseudomonas 
(Allen & Jacoby, 1969) species involved in the conversion of 2,3-
epoxysuccinate into tartaric acid and a Flavobacterium sp. converting 
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dibromopropanol into glycerol (Castro & Bartnicki, 1968). The latter 
bacterium contains a halohydrin epoxidase capable of converting a 
halohydrin into an epoxide. Due to increased interest in the degradation of 
environmentally important halogenated compounds, a number of bacterial 
epoxide hydrolases have been studied in bacteria containing halohydrin 
epoxidases (Van Den Wijngaard et al, 1989, Kasai et al, 1992, 
Nakamura et al., 1994). Furthermore, epoxide hydrolases from other 
bacterial sources (Michaels et al., 1980, De Bont et al, 1982, Rustemov et 
al, 1991, Hechtberger et al, 1993, Madyasta & Gururaja, 1993, Carter & 
Leak, 1995) as well as from fungal (Chen et al., 1993, Pedragosa-Moreau 
et al, 1993, Zhang et al, 1995, Nellaiah et al., 1996) and yeast (Weijers, 
1997) sources have been identified. In biotransformation studies, some of 
these epoxide hydrolases are very effective for the enantioselective 
hydrolysis of epoxides (Chen et al., 1993, Hechtberger et al., 1993, 
Pedragosa-Moreau et al., 1993, Nakamura et al., 1994, Carter & Leak, 
1995, Mischitz et al., 1995, Zhang et al., 1995, Nellaiah et al, 1996, 
Weijers, 1997). 
In contrast to the epoxide hydrolases of mammals, the microbial epoxide 
hydrolases have received only limited attention from molecular biologists. 
Some bacterial epoxide hydrolases have been purified and characterized 
(Jacobs et al., 1991, Nakamura et al, 1994, Mischitz et al., 1995). From a 
Pseudomonas sp. (Jacobs et al., 1991) a Corynebacterium sp. (Yu et al., 
1994) and Stigmatella sp. (EMBL accession number: Q06816), (partial) 
amino acid and DNA sequences have been determined. Especially, the 
sequences of Corynebacterium and Stigmatella do show similarity to the 
known mammalian epoxide hydrolases. The two C-terminal amino acids 
of the three amino acids proposed to form the catalytic triad of soluble 
epoxide hydrolase (Arand et al, 1996) are easily identified in these 
sequences, indicating that these bacterial epoxide hydrolases probably 
have the same reaction mechanism as proposed for mammalian epoxide 
hydrolases. 
EPOXIDES AS INTERMEDIATES IN BIOSYNTHESIS 
Epoxides are not only a toxicological problem for microorganisms but are 
also used for the synthesis of complex molecules. Here the formation of 
three of these molecules is discussed. This shows the broad diversity of 
reactions occurring with an epoxide intermediate. 
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Fig. 2. Conversion of ' 
epoxides as 
intermediates in 
biosynthesis. 
(a) The epoxide 
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oxidosqualene 
cyclases leads to the 
formation of a four-
ring structure. 
(b) Decarboxylation 
and reduction leads 
to the formation of 
the third ring (ring C) 
of chanoclavine-l, an 
intermediate in the 
formation of ergot 
alkaloid. 
(c) The oxygen of 
epoxyqueuosine is 
eliminated and 
reduced to the 
double bond found in 
queuosine. 
COOH 
OH 
OH 
IjJH 
OH 
OH 
NH 
CH2 
R 
The best-studied reaction is found in the biosynthesis of lanosterol in 
Saccharomyces cerevisiae and Candida albicans. In this reaction, opening 
of the epoxide initiates the formation of a four-ring structure (Fig. 2a). 
This remarkable reaction has been studied extensively and oxidosqualene 
cyclases from C. albicans (Buntel & Griffin, 1992) and S. cerevisiae 
(Corey et al., 1994, Shi et al., 1994) have been cloned and sequenced. The 
amino acid sequences deduced from the nucleotide sequences are 
unusually rich in tryptophan and tyrosine which have electron-rich side 
chains thought to be involved in the folding of the substrate in the active 
site and in the stabilization of the transition states or intermediates (Shi et 
al, 1994). 
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In the fungus Claviseps strain SD 58, opening of an epoxide leads to the 
formation of the third ring of chanoclavine-I (Kozikowski et al., 1993) 
(Fig. 2b). This is an intermediate in the formation of ergot alkaloid. No 
enzymatic confirmation on the reduction and decarboxylase steps has yet 
been obtained. 
A third example of an epoxide as an intermediate in biosynthesis is 
epoxyqueuosine involved in the synthesis of queuosine (Slany & Kersten, 
1994). Queuosine is a tRNA nucleoside usually replacing the guanosine in 
the anticodon of tRNAscuN of eubacteria and cytoplasmic and 
mitochondrial tRNAs of eukaryotes other than yeast. Queuosine is 
produced de novo only in prokaryotes while eukaryotes get the free base 
queuine from their nutrients. The last step in the biosynthesis involves 
reduction and elimination of the oxygen of the epoxy group of 
epoxyqueuosine to a double bond of queuosine (Frey et al., 1988) (Fig. 
2c). Apart from the fact that this step requires vitamin B^, nothing is 
known about the catalytic mechanism, proteins, or genes involved in this 
reaction. 
THE CONVERSION OF EPOXIDE INTERMEDIATES IN DEGRADATION PATHWAYS 
Examples are presented of three different degradation routes involving an 
epoxide as a reaction intermediate. In all of these cases, the epoxides to be 
degraded are formed by the action of monooxygenases. 
The degradation of a-pinene by Nocardia sp. and Pseudomonas sp. 
In Nocardia sp. strain PI8.3 as well as in Pseudomonas fluorescens 
NCIMB 11671, a-pinene oxide is an intermediate of a-pinene 
degradation (Best et al., 1987, Griffith et al, 1987). An NADH-linked 
monooxygenase is responsible for the formation of the epoxide. An a-
pinene oxide lyase catalyzing the cleavage of both the carbocyclic rings of 
a-pinene oxide (Griffith et al, 1987) (Fig. 3a) has been purified. The 40 -
50 kDa protein is a heterodimer of 22 kDa and 17 kDa subunits. No 
exogenous cofactors are necessary for the reaction. The substrate 
specificity, however, is very limited. The only substrate known is a-
pinene oxide. The inhibition of the protein by sulfhydryl active agents 
suggests the involvement of thiol groups in the rearrangement reaction. A 
mechanism has been proposed in which the epoxide group is destabilized 
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by addition of a proton to the epoxide group followed by a cascade of 
rearrangement reactions leading to opening of the ring structure of oc-
pinene oxide (Griffith et al., 1987) (Fig. 3a). 
Styrene oxide isomerase 
Styrene oxide is an intermediate in the degradation pathway of styrene 
involving an attack on the side chain rather then on the aromatic ring 
(Warhurst & Fewson, 1994). Several bacteria and fungi are able to 
convert styrene oxide to phenylacetic acid (Shirai & Hisatsuka, 1979, 
Baggi et al, 1983, Bestetti et al, 1984, Hartmans et al, 1989, Cox et al, 
1993). Two different degradation pathways have been postulated. Shirai 
and Hisatsuka (1979) and Bestetti et al. (1984) proposed a reduction of 
the styrene oxide by Pseudomonas to 2-phenylethanol while it was 
concluded that the conversion of the epoxide by Xanthobacter 124X 
yielded phenylacetaldehyde (Hartmans et al, 1989). Other strains, 
including a fungus, Exophilia jeanselmei (Cox et al, 1993) degraded 
styrene oxide using the same pathway (Hartmans et al, 1990). According 
to Hartmans et al. (1995) the degradation product, 2-phenylethanol found 
Fig. 3. Conversion of 
epoxide 
intermediates in 
degradation 
pathways. 
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by Shirai and Hisatsuka (1979) and Bestetti et al. (1984) was the result of 
the reduction of 2-phenylacetaldehyde to 2-phenylethanol by an alcohol 
dehydrogenase. This suggests that these organisms also contained a 
styrene oxide isomerase (Hartmans, 1995) (Fig. 3b). Recently, Marconi et 
al. (1996) reported the cloning of the styrene catabolic genes from P. 
fluorescens ST. 
Epoxyalkane degradation in Xanthobacter Py2 
In recent years, a number of studies on alkene and epoxyalkane 
degradation by Xanthobacter Py2 have been published. The strain is 
examined not only for its monooxygenase involved in the epoxidation of 
the alkenes (Van Ginkel & De Bont, 1986, Van Ginkel et al, 1986, 
Ensign et al., 1992, Zhou et at., 1996), and its cometabolic degradation of 
chlorinated compounds (Weijers et al., 1988, Reij et al., 1995, Small et 
al., 1995), but also for its enantioselective degradation of epoxyalkanes. 
Weijers et al. (1995) reported the degradation of epoxyalkanes (C2-C6) by 
Xanthobacter Py2. Both enantiomers of 1,2-epoxyalkanes are degraded, 
however, with racemic mixtures of 2,3-epoxyalkanes, the 2S forms are 
degraded. This leaves optically pure 2R-2,3-epoxyalkanes. 
The epoxyalkane degradation has been studied in more detail by Weijers 
et al. (1995) in crude extracts of propene-grown Xanthobacter Py2. It was 
shown that the degradation of epoxyalkanes was completely dependent on 
NAD and a unidentified low molecular mass fraction. Dithiol compounds 
like DTT and 1,3-propanedithiol could replace this low molecular mass 
fraction while monothiols were unable to replace the fraction. 
Both ketones (Weijers et al., 1995) and B-keto acids (Small & Ensign, 
1995, Allen & Ensign, 1996) have been detected as the degradation 
product of epoxyalkane conversion. B-Keto acids are formed by 
carboxylation of the epoxyalkane (Fig. 3c) while the ketones are thought 
to be formed only in the absence of carbonate and are not true 
intermediates in epoxyalkane degradation. 
Swaving et al. (1995) isolated several mutants of Xanthobacter Py2 
unable to grow on 1,2-epoxypropane. One of these mutants was used for 
complementation studies restoring growth on 1,2-epoxypropane. A 4.8 kb 
subclone complementing the mutation of Xanthobacter Py2M10 was 
isolated. Using this clone for heterologous expression experiments, 
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epoxide degradation was detected in Xanthobacter autotrophicus GJ10. 
The sequence of the 4.8 kb subclone revealed four open reading frames. 
The first two open reading frames showed little or no homology with 
known proteins. ORF3 resembled pyridine nucleotide disulfide 
oxidoreductases. ORF4 had homology with 3-oxoacyl reductases. 
Although it is not clear how these proteins are involved in epoxide 
degradation, Swaving et al. (1996) and Chan Kwo Chion & Leak (1996) 
showed that the ORF1 and ORF3 proteins play a role in this process. The 
ORF3 protein was purified and characterized (Chapter 5 of this thesis) and 
shown to be NADPH dependent. It was found that NADPH could replace 
the low molecular mass fraction and it was proposed to be the 
physiological cofactor (Swaving et al., 1996, Chan Kwo Chion & Leak, 
1996). The dithiols, which may replace the low molecular mass fraction, 
are able to reduce the redox active disulfide bridge of the ORF3 protein 
directly whereas NADPH donates electrons via FAD bound to the ORF3 
protein (Swaving et al., 1996) 
Conclusions 
The degradation of epoxides by microorganisms is extremely diverse. The 
reactivity of the epoxide group enables the organisms to use this epoxide 
for very different types of reactions, S^-types of reactions, reactions with 
or without cofactors, isomerization, and carboxylation. In some cases the 
opening of the epoxide ring changes the whole overall structure of the 
compound. 
Surprisingly, only little information is available on one particular type of 
epoxyalkane conversion: the reduction of the epoxide group to an alcohol. 
In rat liver homogenate this type of reduction has been observed 
(Steckbeck et al., 1982). In microorganisms, some (incomplete) data has 
been published on reduction of epoxides. For example, the degradation of 
limonene to a-terpeneol via a limonene oxide intermediate (Fig. 4a) has 
been suggested (Kieslich et al., 1986). Recently, also the reduction of p-
nitrophenyl-l,2-epoxyheptan-3-one to p-nitrophenyl-2,3-
dihydroxyheptane by 5. cerevisiae (Fig. 4b) has been reported, (Horak et 
al., 1995) but both examples lack information on the enzymology of the 
reduction described. 
14 Chapter 2 
Fig. 4. Reduction of 
epoxides. 
(a) a-Terpeneol is 
formed from 
limonene via 
reduction of the 
epoxide group of the 
limonene oxide 
intermediate. 
(b) p-Nitrophenyl-1,2- b 
epoxyheptan-3-one is 
reduced by 
Saccharomyces 
cerevisiae to p-
nitrophenyl-2,3- Q2 
dihydroxyheptane. 
OH 
O2I 
Curiously, bacteria degrading alkenes via an epoxide intermediate have 
developed an epoxide-degrading system different from the effective and 
relative simple epoxide hydrolases. As discussed before, Xanthobacter 
Py2 has developed a very complex enzyme system for the degradation of 
epoxyalkanes. Several other Xanthobacter and Nocardia species isolated 
on alkenes probably have the same type of epoxyalkane-degrading 
system. Nocardia A60 isolated on 1,2-epoxypropane used an epoxide 
hydrolase and was lacking an alkene monooxygenase (De Bont et al., 
1982). These observations indicate that the complex epoxyalkane-
degrading system is linked to an alkene monooxygenase as has been 
suggested previously (Zhou et al, 1996, Ensign, 1996). 
OUTLOOK FOR APPLYING EPOXIDE-DEGRADING ENZYMES 
Epoxide-degrading enzymes may be of practical use in the 
enantioselective degradation of cheaply available racemic mixtures of 
epoxides. The resulting enantiopure epoxide may be a very valuable 
compound in the further syntheses of biologically active compounds; 
however, not all of the enzymes discussed here are good candidates for 
applying them in a biotechnological process. 
Glutathione transferases suffer from their inherent dependency on 
glutathione as cofactor. As a consequence, even if more than one 
enantioselective enzyme (Zhang et al., 1995) is to be discovered, it 
remains questionable if the glutathione transferases will be applied. 
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Styrene oxide isomerases are not enantioselective. Furthermore, they do 
not yield an enantiopure product. These enzymes therefore are not good 
candidates for industrial applications. 
The epoxyalkane-degrading enzyme as characterized in Xanthobacter Py2 
has very interesting properties because it is able to degrade certain 2,3-
epoxyalkanes in a completely enantioselective way. The problem here is 
that the enzyme system is very complex, and needs cofactors. As a 
consequence, it cannot be applied outside a metabolically active cell. 
Furthermore, the range of racemic epoxide mixtures degraded 
enantioselective is restricted to a few compounds only. 
The most promising enzyme from a practical point of view beyond any 
doubt is the epoxide hydrolase. These enzymes have now been detected in 
many microorganisms. Depending on the microbial source, they have 
different substrate specificities and enantioselectivities. If a specific 
bioconversion is required, it then seems possible to screen for a suitable 
epoxide hydrolase for the specific bioconversion. 
Some of the epoxide-degrading enzymes such as the oc-pinene oxide lyase 
and epoxide reductases have not been studied in sufficient detail yet to 
allow an assessment of their practical applications. 
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Microbiology (1995), . - » « . . - . 141,477484 complementing DNA fragment 
Jelto Swaving, Carel A. G. M. Weijers, Albert J. 
J. van Ooyen and Jan A. M. de Bont 
Three Xanthobacter Py2 mutants (M3, M8 and M10) lacking 
epoxyalkane-degrading activity were isolated and characterized. 
All mutants were able to grow on acetone, the degradation 
product of 1,2-epoxypropane conversions. Furthermore, they 
contained the unidentified 'low molecular mass fraction' (LMF) 
necessary for epoxyalkane-degrading activity. Three cosmids 
from a gene bank complemented the mutation in M10 and M8 but 
not in mutant M3. Epoxyalkane-degrading activity in crude 
extracts of 1,2-epoxypropane-grown complemented mutants was 
similar to the wild-type activity. Surprisingly, M10 transformed 
with complementing cosmid pEP9 showed a constitutively 
expressed epoxyalkane-degrading activity, which was not 
observed in the wild-type strain. The cosmid pEP9 was 
conjugated into Xanthobacter autotrophicus GJ10, which is not 
able to degrade 1,2-epoxypropane. In crude extracts of X. 
autotrophicus GJ10(pEP9), epoxyalkane-degrading activity was 
demonstrated, but only after the addition of the LMF from 
Xanthobacter Py2. Hybridization experiments demonstrated an 
overlap on complementing cosmids pEP1, pEP3 and pEP9. 
Subcloning revealed a 4.8 kb EcoRI-H/ndlll fragment to be 
necessary for complementing the mutant M10. In the sequence 
of this fragment four different ORFs were found. 
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Introduction 
Several methods have been described to produce optically pure epoxides by 
biological methods (Weijers etal, 1988b, Leak et al, 1992, De Bont, 1993). 
One such method is the enantioselective degradation of racemic epoxides; 
however, such a process yields a maximum of 50 % product. Xanthobacter 
Py2 was isolated on propene as sole carbon and energy source (Van Ginkel 
& De Bont, 1986). This strain is able to degrade the (25)-forms of trans-2,3-
epoxybutane and 2,3-epoxypentane, resulting in optically pure (2/f)-2,3-
epoxyalkanes; the C3-C6 1,2-epoxyalkanes are degraded completely 
(Weijers et al, 1988a). 
Fig. 1. The proposed 
degradation pathway 
of epoxyalkanes by 
Xanthobacter Py2. 
The X-(SH)2 
represents the LMF 
necessary for 
epoxyalkane 
degradation (Weijers 
etal., 1995) 
R1", A J*2 
H H 
X-(SH)2 
X-S2 
NAD+ 
NADH + H+ 
Rl—CH 2—C— R2 
Ketones have been identified as degradation products of epoxyalkane 
metabolism in crude extracts of propene-grown cells (Fig. 1). It has been 
demonstrated that both NAD and an unidentified 'low molecular mass 
fraction' (LMF) are involved in the reaction. In a reaction mechanism 
proposed by Weijers et al. (1995) it was suggested that the LMF is 
involved in the reduction of the epoxyalkanes to secondary alcohols since 
the LMF can be replaced by reducing compounds like DTT and other 
dithiol compounds. The presence of NAD is necessary for the oxidation of 
the alcohols to the corresponding ketones. 
Attempts to purify the epoxyalkane-degrading enzyme have not been 
successful. Consequently, we have now investigated the genetics of 
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epoxyalkane degradation in Xanthobacter Py2. Eventually, we hope to be 
able to obtain the enzyme to study further its reaction mechanism. 
In this study we report the selection and characterization of mutants devoid 
of epoxyalkane-degrading activity, the complementation of these mutants 
and the expression of one of the complementing cosmids in Xanthobacter 
autotrophicus GJ10. In addition, a 4.8 kb fragment complementing the M10 
mutation was sequenced and analyzed. 
Methods and Materials 
GENERAL METHODS 
MUTANT ISOLATION 
Strains and plasmids used in this study are listed in Table 1. Escherichia 
coli cells were grown on LB medium (Sambrook et al., 1989). 
Xanthobacter strains were grown at 30°C on yeast extract-glucose 
medium (10 g 1 each) or in sealed flasks with mineral medium (Wiegant 
& De Bont, 1980) to which 5 mM volatile compound was added to the 
water phase or 5% (v/v) propene added to the gas-phase. For induction of 
the epoxyalkane-degrading activity, cells were grown in yeast extract-
glucose medium (750 ml) in sealed 5 1 flasks to which 1% propene was 
added to the gas phase as inducing agent. Cells cultivated on plates were 
placed in a desiccator when a volatile compound was used as a substrate; 
for each plate (20 ml) 0.1 mmol of the substrate was added to give a final 
concentration of 5 mM. The antibiotics used for the selection of plasmids 
were tetracycline (12.5 |0.g ml" ), ampicillin and kanamycin (both 50 u,g 
ml" ). Preparation of crude extracts, and LMF, and the activity assay for 
epoxyalkane degradation in which the initial degradation rate of 1,2-
epoxypropane in extracts is followed using head-space GC analysis have 
been described by Weijers et al., (1995). 
Exponentially growing cultures (5 ml) of Xanthobacter Py2 grown on 
propene were UV-irradiated until less than 1% of the cells survived. The 
cells were placed in the dark in 20 ml liquid mineral medium with 5 mM 
acetone until growth was visible. The cells were harvested by 
centrifugation at 15,000 g for 5 min, washed and resuspended in the same 
volume of mineral media containing 1,2-epoxypropane. Glycine (2%, 
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Table 1. Bacterial strains and cosmids used. 
Organism or 
cosmid 
E. coli 
LE392 
TGI 
HB101 
Xanthobacter 
Py2 
Py2M3 
Py2M8 
Py2M10 
GJ10 
Cosmids 
pLAFR5 
pEPl, -3, -9 
pRK2013 
pT7/T3-19 
Relevant properties 
RecA" 
RecA" 
RecA" 
epoxyalkane using wild-type 
defective in epoxyalkane degradation 
defective in epoxyalkane degradation 
defective in epoxyalkane degradation 
growth on acetone, not on epoxyalkanes 
Tc , RK2 replicon, mob 
pLAFR5 containing X Py2 DNA 
tra (RK2), ColEl replicon, Km' 
Ap, pUC19 derivative 
Reference 
Sambrook etal., (1989) 
Sambrook^a/.,(1989) 
Boyer & Roulland-Dussoix (1969) 
Van Ginkel & De Bont (1985) 
this study 
this study 
this study 
Janssen et al., (1985) 
Keen et al., (1988) 
this study 
Figurski & Helinski (1979) 
Life Technologies 
w/v) was added after 8 h incubation to kill growing cells. After overnight 
incubation in the glycine-containing medium, the cells were harvested and 
washed in sterile demineralized water. Recovery, starvation and killing of 
the cells was repeated once more before spreading them on yeast extract-
glucose plates. 
GENE BANK PREPARATION 
Total DNA was prepared from propene-grown wild-type Xanthobacter 
Py2 cells. Cells from 750 ml cultures were harvested, resuspended in 25 
ml TEG (10 mM Tris, 1 mM EDTA, 50 mM glucose, pH 8.0) and lysed 
by the addition of SDS (2%, w/v, final concentration). Proteins were 
removed by extraction with phenol/chloroform, and DNA was 
precipitated with 2-propanol. Purified DNA was dissolved in TE buffer, 
partially digested with Sau3A and dephosphorylated. The two pLAFR5 
cosmid arms were prepared by digestion with Seal and BamHI (Keen et 
al., 1988). Ligated DNA was packaged using the Packagene in vitro 
packaging system supplied by Promega and used to transduce E. coli 
LE392; the transduced cells were spread on plates (100-200 colonies per 
plate). After overnight growth cells were resuspended and pooled in LB 
supplemented with 30% glycerol and stored at -80°C. 
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TRIPARENTAL MATING 
This was carried out essentially as described by Janssen et al. (1989) but 
instead of NB agar, yeast extract-glucose agar was used. The conjugated 
recipient strains were selected on tetracycline-containing mineral medium 
agar plates with either 1,2-epoxypropane or 2-propanol as substrate. 
DAM MANIPULATIONS, SOUTHERN-TRANSFER, HYBRIDIZATION AND NUCLEOTIDE SEQUENCE 
Standard recombinant DNA techniques were performed as described by 
Sambrook et al. (1989). DNA was isolated from agarose gel using 
Geneclean II (Bio 101). For Southern transfer, digested cosmid DNA was 
separated on a 0.7% agarose gel, blotted onto a nylon membrane (Nytran 
NY 13N; Schleicher & Schuell) by capillary transfer and fixed on the 
membrane by UV-irradiation for 2 minutes. Probes used were prepared 
using the DIG DNA labeling and detection kit (Boehringer). 
Hybridization and detection were performed using the same kit, except 
that the hybridization temperature was 71°C. A 4.8 kb EcoRI-Hindlll 
fragment was ligated into plasmid pT7/T3oc-19. The insert was sequenced 
in both directions by Pharmacia Biotech Benelux using the primer 
walking method. Nucleotide sequencing was performed using the dideoxy 
chain-termination method (Sanger et al., 1977) using 5'-FITC-labelled 
primers. Computer analysis of the sequence was accomplished with the 
Staden program. 
Results 
ISOLATION OF XANTHOBACTER PY2 MUTANTS DEVOID OF EPOXYALKANE-DEGRADING ACTIVITY 
The complementation method used for the isolation of Xanthobacter Py2 
DNA sequences involved in epoxyalkane degradation by Xanthobacter Py2 
requires mutants defective in the protein responsible for epoxyalkane 
degradation. To ensure that only this protein is mutated and not enzymes 
further down the degradation pathway, these mutants should still be able to 
grow on acetone, the first detectable degradation product of 1,2-
epoxypropane. These mutants should also contain the unidentified 'low 
molecular mass fraction' (LMF) required for epoxide degradation. 
Mutants were obtained as described in Methods. Single colonies were 
streaked on mineral medium plates and incubated for one week in a 
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desiccator containing 1,2-epoxypropane. Wild-type cells able to grow on 
1,2-epoxypropane formed large slimy colonies while mutant cells formed 
very small colonies. Of the 450 putative mutants tested, 23 did not grow on 
1,2-epoxypropane. These small colonies were sub-cultured twice on mineral 
medium plates with 1,2-epoxypropane as substrate. This procedure resulted 
in 11 mutants unable to grow on 1,2-epoxypropane. These 11 mutants were 
tested for growth in liquid containing 1,2-epoxypropane; three mutants did 
not grow. These mutants designated M3, M8 and M10, all grew on acetone 
with growth rates comparable to wild-type Xanthobacter Py2. 
CHARACTERIZATION OF THE MUTANTS DEFECTIVE IN EPOXYALKANE DEGRADATION 
The three mutants devoid of epoxyalkane-degrading activity were tested for 
the presence of the LMF. In wild-type Xanthobacter Py2 no epoxyalkane-
degrading activity was found when cells were grown on yeast extract-
glucose medium; however, when 1% propene was added to the head-space 
during growth on yeast extract-glucose, low activities were observed 
[approx. 2 nmol 1,2-epoxypropane degraded min" (mg protein)" ]. Crude 
extracts of mutant cells grown on yeast extract-glucose in the presence of 1 
% propene showed no epoxyalkane-degrading activity. These crude extracts 
were used for the preparation of the LMF and the protein fraction. By 
combining the protein fraction of the wild-type Xanthobacter Py2 grown on 
1,2-epoxypropane with the LMF of a mutant, it is possible to detect whether 
the LMF is present in the mutant. The combination of the active protein 
fraction of the wild-type Xanthobacter Py2 with the LMF of the mutants 
resulted in epoxyalkane-degrading activity between 4 and 6 nmol 1,2-
epoxyalkane degraded min" (mg protein)" . The specific activity of 
combined wild-type Xanthobacter Py2 LMF and protein fraction was 12 
nmol 1,2-epoxyalkane degraded min (mg protein)" . No activity was 
detected when the LMF of the wild-type Xanthobacter Py2 was combined 
with the protein fraction of the mutant cells. These results show that the 
LMF is still present in the three mutants and that the protein fractions of the 
mutants are inactive. 
COMPLEMENTATION OF XANTHOBACTER PY2 MUTANTS 
The broad-host-range cosmid pLAFR5 was used as a cloning vector for 
Xanthobacter Py2 because of its ability to replicate in Xanthobacter species 
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(Janssen et al., 1989). The vector contains a double cos site, allowing the 
insertion of relatively large DNA fragments. 
Screening of the gene bank with an average insert size of 17 kb was by 
individually transferring the recombinant cosmids from the transduced E. 
coli LE392 to the recipient mutant M10 using triparental mating as 
described in the Methods section. The conjugated recipients were selected 
for growth on mineral medium plates in the presence of tetracycline and 
using 1,2-epoxypropane as substrate. Nine tetracycline resistant colonies 
were able to grow on the substrate. To rule out reversion of the mutation and 
to eliminate unstable cosmids, the nine cosmids were isolated from these 
complemented M10 colonies, used to transformed to E. coli TGI and again 
conjugated into M10. Five out of nine cosmids (pEPl, pEP3, pEP4, pEP5 
and pEP9) restored the ability to grow on 1,2-epoxypropane both on plates 
and in liquid mineral medium. 
Restriction enzyme analysis of the five different cosmids with BamHl, Xhol, 
EcoRl and Sail revealed that the restriction pattern of pEP3 was identical to 
pEP4; the same was observed for pEP5 and pEP9, leaving three different 
cosmids (pEPl, pEP3 and pEP9) complementing M10. The insert sizes of 
the three different cosmids were 24 kb, 26 kb and 22 kb for pEPl, pEP3 and 
pEP9, respectively. 
The three cosmids were conjugated into the mutants M3 and M8. They 
complemented M8 as seen from good growth on plates in the presence of 
1,2-epoxypropane. The M3 mutation, however, was not complemented by 
the cosmids. A subsequent conjugation of 2200 clones from the gene bank 
into the M3 did not yield any cosmid restoring its ability to grow on 1,2-
epoxypropane. 
EPOXYALKANE-DEGRADING ACTIVITY IN COMPLEMENTED MUTANT CELLS 
Epoxyalkane-degrading activity was measured in crude extracts of mutants 
M8 and M10 grown under different conditions. The activities of cells grown 
on 1,2-epoxypropane was comparable to the wild-type Xanthobacter Py2 
[13±2 nmol min" (mg protein)" ]. Surprisingly, the M8 and M10 mutants 
complemented with pEP9 showed a rather high epoxyalkane-degrading 
activity of 22 nmol min" (mg protein) when grown on yeast extract-
glucose medium, indicating constitutive expression. This was not observed 
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F/g. 2. (A) The restriction map of the 22 kb insert of pEP9. The lines on top represent the 
probes used for the Southern hybridization with pEP1, pEP3 and pEP9 (Fig. 3). Restriction 
enzymes used: B: BamH\; E: EcoRI; X: XhcA and H: H/ndlll. The restriction enzymes in italics 
belong to the multiple cloning site of the vector. (B) The deletion clones of pEP9. pEP9.1 is a 
BamVW and pEP9.2 is an EcoRI deletion clone. 
in wild-type Xanthobacter Py2 cells nor in the mutants M8 and M10 
complemented with pEPl or pEP3. 
COFACTOR DEPENDENT EPOXYALKANE-DEGRADING ACTIVITY IN XANTHOBACTER 
AUTOTROPHICUS GJ10 
The plasmid pEP9, which constitutively expressed epoxyalkane-degrading 
activity in M8 and M10 was conjugated into X. autotrophicus GJ10. This 
Xanthobacter strain is not able to grow on epoxyalkanes. Conjugants were 
selected on mineral medium plates containing tetracycline and 2-propanol. 
The conjugated X. autotrophicus GJ10 was not able to grow on 1,2-
epoxypropane, and no epoxyalkane-degrading activity was detected in crude 
extracts of cells grown on yeast extract-glucose grown cells. However, 1,2-
epoxypropane was degraded by these extracts [2 nmol 1,2-epoxypropane 
degraded min" (mg protein)" ] if the LMF prepared from propene-grown 
Xanthobacter Py2 cells was added. No such activity was found when the 
LMF was added to crude extracts of wild-type X. autotrophicus GJ10. 
RESTRICTION MAP OF PEP9 AND HYBRIDIZATION STUDIES WITH PEP1 AND PEP3 
Because pEP9 carries the information for epoxyalkane-degrading activity, as 
seen from X. autotrophicus GJ10 conjugated with pEP9, this cosmid was 
further characterized. A restriction map of pEP9 was constructed based on 
migration patterns of digested pEP9 and on Southern hybridization of 
digests of pEP9 with several probes from the pEP9 insert (Fig. 2). 
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Fig. 3. Southern 
hybridization studies 
of X/wl-digested 
pEP1 (lanel), pEP3 
(lane 3), and pEP9 
(lane 9). (A) is the 
digest and the blot 
hybridized with 
probe 1 (Fig. 2). (B) 
is the digest and 
probe hybridized 
with probe 2. 
1 3 9 1 
5.2 kb 
1.4 kb-
Southern hybridizations of Xhol digests of pEPl, pEP3 and pEP9 are shown 
in Fig. 3. The blots were hybridized to two different probes of pEP9 (Fig. 2). 
Probe 1 is a 2.5 kb EcoRl-XhoI fragment (from 8 kb to 10.5 kb on the map) 
and probe 2 is a 1.4 kb Xhol fragment (from 19.6 kb to 21 kb on the map). 
Probe 1 hybridized only to a 5.2 kb Xhol fragment of pEP3, probe 2 
hybridized to both pEPl and pEP3. Further restriction analysis with Xhol 
(Fig. 3), EcoRl, Sail and BamHl showed that pEP3 is homologous to pEP9 
from approximately 5 kb to 22 kb on the pEP9 map. The cosmid pEPl 
showed considerably less homology with both pEP3 and pEP9. Restriction 
homology with Xhol (Fig. 3) and Sail was only found from the 18 kb point 
to approximately the 21.5 kb point of cosmid pEP9. 
SUBCLONING OFPEP9 
The homology studies with pEPl in particular indicated that the 
complementing area was present on the right-hand end of pEP9 (Fig. 3). 
Therefore, this part of pEP9 was used to construct subclones. Cosmid pEP9 
was digested with BamHl or EcoRl and religated to delete the internal 
fragments. The resulting cosmids were checked by restriction analysis and 
assayed for complementation of the mutant M10. The BamHl and the EcoRl 
deletion clones of pEP9, designated pEP9.1, and pEP9.2, respectively, had 
the ability to complement mutant M10 (Fig. 2). The nucleotide sequence of 
the complementing 4.8 kb EcoRI-T/indlll fragment of pEP9.2 was 
determined. 
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NUCLEOTIDE SEQUENCE OF THE 4.8 KB COMPLEMENTING FRAGMENT OF PEP9.2 
The nucleotide sequence of the 4.8 kb complementing part of pEP9 is 
presented in Fig. 4. The G + C content of the fragment was 65.4 mol %, 
which is lower than the 70 mol % found in Xanthobacter Py2 (Van Ginkel 
& De Bont, 1986). Four different ORFs were found, using a codon 
preference normally observed for Xanthobacter DNA. The four ORFs code 
for proteins of 41690, 7388, 57315 and 26111 Da, respectively. In the 
opposite strand no ORFs of significant length were found. 
A computer search of the Swiss-Prot protein bank did not reveal homology 
for the first two ORFs. But interestingly, ORF3 showed significant 
homology with mercury (II) reductase (E.C. 1.16.1.1) from Bacillus strain 
RC607 (P16171), glutathione reductase (NADPH) (E.C. 1.6.4.2) from 
Pseudomonas aeruginosa (P23189) and with dihydrolipoamide 
dehydrogenase (E.C. 1.8.1.4) from pig (P09623). For ORF4, homologies 
were found with 3-oxoacyl reductase (E.C. 1.1.1.35) from Cuphea 
lanceolata (P28643) and glucose 1-dehydrogenase (E.C. 1.1.1.47) from 
Bacillus subtilis (P12310). 
Discussion 
Three major problems are encountered concerning the isolation of the gene 
or genes responsible for the epoxyalkane degradation in Xanthobacter Py2. 
The first problem is the absence of a purified enzyme (Weijers et al, 1994). 
The information gained from a purified enzyme is of great importance for 
both the understanding and the cloning of any enzyme. The second problem 
encountered is the low specific activity of the enzyme. The specific 
epoxyalkane-degrading activity measured in crude extracts with 1,2-
epoxypropane is only 13 nmol per minute per mg protein. For trans-2,3-
epoxybutane, which is degraded enantioselective, this activity is even more 
than 10 times lower (±1 nmol per minute per mg protein). Consequently, 
1,2-epoxypropane was chosen as the model substrate to monitor epoxide-
degrading activity. The third problem is the cofactor requirement in the 
epoxyalkane-degradation. Apart from NAD another yet unidentified factor is 
necessary for activity. This cofactor requirement makes the isolation of the 
epoxyalkane-degrading protein or expression of the cloned genes in other 
strains more difficult. Recently it has been demonstrated DTT replaces the 
unknown cofactor (Weijers et al, 1995). In the present study the 
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physiological low molecular weight fraction rather than the artificial 
cofactor has been used to avoid any possible artifacts. 
In view of the above difficulties, it was decided to isolate mutants lacking 
epoxyalkane-degrading activity which, subsequently, in complementation 
studies were used for the isolation of the gene or genes involved in the 
epoxyalkane degradation. 
The procedure for creating and selecting mutant Xanthobacter strains used 
in this study was very successful. The three mutants selected met all the 
requirements to be of use in the complementation studies. They were unable 
to grow on 1,2-epoxypropane, but grew on acetone, the product of 1,2-
epoxypropane degradation. Furthermore they contained the LMF. 
Three different cosmids were found restoring the ability to grow on 1,2-
epoxypropane using the randomly chosen mutant M10 for complementation 
experiments. Cosmids found with mutant M10 were also able to 
complement the M8 mutant. The epoxyalkane-degrading activities of the 
complemented mutants M8 and M10 were comparable to the wild-type 
Xanthobacter Py2. A special case, however, is the mutant M3. The finding 
that this mutant is not complemented by the cosmids suggests that this 
mutant belongs to a complementation group different from M8 and M10. 
However, the inability to complement this mutant with the Xanthobacter 
Py2 gene bank shows that the M3 mutation is more complex. 
The complementation of mutants lacking epoxyalkane-degrading activity 
does not automatically imply that the genes responsible for the activity have 
been cloned. The mutants can be mutated in the structural genes but also in 
the regulatory regions. To ensure that the catalytic protein was cloned, the 
cosmid pEP9 was conjugated to Xanthobacter autotrophicus GJ10. 
Although the GJ10 harboring pEP9 did not grow on 1,2-epoxypropane, the 
protein required for epoxyalkane-degrading activity was present in extracts 
of yeast extract-glucose grown cells. This was demonstrated by combining 
LMF obtained from the wild-type Xanthobacter Py2 with the protein 
fraction of Xanthobacter autotrophicus GJ10 harboring pEP9, which 
resulted in 1,2-epoxypropane degradation and acetone formation. 
At this point it remains open to further investigation which open reading 
frames code for the one or more proteins involved in epoxyalkane 
degradation. At present the epoxide-degrading enzyme has been 
characterized to a limited extend only, but a reaction mechanism has been 
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put forward (Weijers et al., 1994). The suggested mechanism involves the 
reduction of a disulfide bridge in the catalytic center of the epoxide-
degrading enzyme. Similarities were noted with vitamin K epoxide 
reductase and very recently the involvement of lipoamide reductase was 
implied in supplying reducing equivalents to the enzyme (Thyssen et al., 
1994). Obviously, in this respect it is very interesting that the ORF3 
protein shows significant homology with lipoamide reductase. 
AAGCTTGGCTGCAGGTCGACGGATCAAGAAAATAGGTGCGGAAGCTTTCCCACTGCTCGGCGGGATTGCGGTAATGCAGG 
10 20 30 40 50 60 70 80 
CAGATGTGGCGATGAAGATGCGCATGGGTGTGCGCGTGGGCCTGCCCCGCCAGGGGCGCGGCTCCGCCGCCGCGGCCGGG 
90 100 110 120 130 140 150 160 
GGCGCGAGGGCAGGGGCGGCGACCTCGCCGACCTCCTCGCTGCGCCCGGCGAGGAAGGCGTCCAGCACCTTGCGATCGAA 
170 180 190 200 210 220 230 240 
TCGCCGCTCGCCGCGCAGGCCGACGCGCAGACAGGCCAATTGGCCGTCGCTCGTCCAGCGGCGCAGGGTCGTCTTGCTAA 
250 260 270 280 290 300 310 320 
ACCCTAGGTATTGGGCGGCTTCCTCGAGGGTAAGCAGGTTGTTCTCTTCATTCATTGCGTCCGTCGTCCTCGGAGCGAGA 
330 340 350 360 370 380 390 400 
ATAGGTTTGACTAACTTCGGACATGTCCCATCGGCTCCTTGGGCATGGCCAATCCTCCCCTTTGGTTTCTTATCGAGCTG 
410 420 430 440 450 460 470 480 
TCCGCCCTCTTAGCACCCTTCGACCCATAACGGAAATGTGCGACAGTCTGGTGCGGTACAGATATGTATGAATAAGATTG 
490 500 510 520 530 540 550 560 
TAATCAAGTCTCGGTGAGCGGCGGGACGCGGCGGAGTGTCCCACGCCCGGGTTCGGCGCCCGGCCGTCCGGATTCGCCGT 
570 580 590 600 610 620 630 640 
TCGGCGCCGGAAAACCCGCAAAAGCTCGAGAATCTCATGCTGGCCCGTGCGAGGCGCTTGACAGCGTCCATGGTCGGTGA 
650 660 670 680 690 700 710 720 
CTAAGAATGATCAACTATAGATAATAATGGCGACTTCCGAGCAGGAATGGTGCTGGAATGTCGTCATCATTGAGAAGGCC 
730 740 750 760 770 780 790 800 
M L 
GACGACGCATCGTGGCCAGGCAGATTGGGTCTGCCGCGGCACGAGACAGTCAGGCGGCATCAGGGAGGATGGGAAT6CTG 
810 820 830 840 850 860 870 880 
I R G E D V T I P T S M V G N Y P N P R W W D A Q F A 
ATCCGAGGGGAAGACGTCACGATTCCGACCAGTATGGTCGGCAACTATCCCAATCCGCGGTGGTGGGACGCCCAGTTCGC 
890 900 910 920 930 940 950 960 
R T W T G D Q E P P D A L I Q E S L E D A V A A I A 
CCGCACCTGGACGGGTGATCAGGAGCCGCCGGACGCGCTGATCCAGGAATCCCTCGAGGATGCGGTGGCTGCCATCGCCC 
970 980 990 1000 1010 1020 1030 1040 
R D Q E R A G L D I I S D G R V H G D N Y A E Q A L Y 
GCGATCAGGAGCGCGCCGGCCTCGACATCATCAGCGACGGCCGCGTGCACGGCGACAATTACGCCGAACAGGCCCTTTAT 
1050 1060 1070 1080 1090 1100 1110 1120 
Y Y Y R R L G Y D L K G G Y L G F P I Y S R L H A G T 
TATTACTACCGGCGCCTCGGCTACGACCTCAAGGGCGGCTATCTCGGCTTTCCGATCTACAGCCGGCTTCACGCGGGCAC 
1130 1140 1150 1160 1170 1180 1190 1200 
L T G E V R R H G A I M V E Q A K A L K K A T G K P 
CCTCACCGGCGAGGTCCGGCGCCACGGCGCGATCATGGTCGAGCAGGCCAAGGCGCTGAAGAAGGCCACTGGCAAGCCCA 
1210 1220 1230 1240 1250 1260 1270 1280 
T K V Q Y T G V Q A L T Q A T N D L H Y K S S R D R A 
CCAAGGTGCAGTATACGGGCGTCCAGGCGCTCACCCAGGCGACCAACGACCTGCACTACAAGTCGAGCCGCGATCGCGCC 
1290 1300 1310 1320 1330 1340 1350 1360 
M A I A K A I N E D I R E V D A L G V D F I Q I D E F 
ATGGCCATCGCCAAGGCCATCAACGAGGACATCCGCGAGGTGGACGCGCTCGGCGTCGACTTCATTCAGATCGACGAGTT 
1370 1380 1390 1400 1410 1420 1430 1440 
T W P Y F F E D W A I E A F N A A V D G V K N A K I 
CACCTGGCCCTATTTCTTCGAGGACTGGGCCATCGAAGCCTTCAACGCGGCGGTGGACGGCGTGAAGAACGCCAAGATCA 
1450 1460 1470 1480 1490 1500 1510 1520 
I A H V C W G N W G G T P A Y Y P D E T A A S G E I F 
TCGCCCATGTGTGCTGGGGCAACTGGGGCGGCACGCCCGCTTACTATCCCGACGAGACGGCGGCCAGCGGCGAGATCTTC 
1530 1540 1550 1560 1570 1580 1590 1600 
D L T K R K A E A T K A T A T G S I V P K A Y E A R L 
GATCTCACCAAGCGCAAGGCGGAAGCCACCAAGGCCACCGCCACCGGCTCCATCGTGCCGAAGGCCTACGAGGCCCGGCT 
1610 1620 1630 1640 1650 1660 1670 1680 
D V L N L E S C G R R S D D L S G L H V M K N H P L 
CGACGTGCTCAACCTGGAAAGCTGCGGGCGCCGCTCCGATGATCTCAGCGGCCTTCACGTGATGAAGAACCATCCCCTGC 
1690 1700 1710 1720 1730 1740 1750 1760 
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P D N V S F W A G V I D V K S T I T E T A D E V A N R 
CGGACAATGTCTCGTTCTGGGCGGGCGTCATCGACGTGAAGAGCACCATCACGGAGACGGCCGACGAGGTGGCAAACCGC 
1770 1780 1790 1800 1810 1820 1830 1840 
I R R L L E I V P A D R L G V T T D C G L I L L Q R Y 
ATTCGCCGGCTGCTGGAGATCGTCCCGGCGGACCGCCTCGGCGTGACCACCGACTGCGGCCTCATTCTGCTCCAGCGCTA 
1850 1860 1870 1880 1890 1900 1910 1920 
I A Q D K L H A L V E G T K I V R A E L A K A K Q A 
TATCGCCCAGGACAAGCTGCACGCCCTCGTCGAGGGCACCAAGATTGTCCGAGCAGAGCTCGCCAAGGCCAAGCAGGCGG 
1930 1940 1950 1960 1970 1980 1990 2000 
A H P 
CCTGATCTAAAGACGTCAGTCATCTTTCAATCGTCCGGGCGAACACATGAGCTCGGGCGATGAGGGAGGAGCCATOCCTG 
2010 2020 2030 2040 2050 2060 2070 2080 
V Y T I K C P D C G H V F R G M V M E G T R K P R V W 
TCTATACCATCAAATGCCCGGACTGCGGCCATGTCTTCCGCGGGATGGTCATGGAGGGCACGCGCAAGCCCCGCGTCTGG 
2090 2100 2110 2120 2130 2140 2150 2160 
V C S Q C K S E R P Q I M A D R P A E P H P F E C T E 
GTGTGCTCCCAGTGCAAGAGCGAGCGGCCACAGATCATGGCCGACCGCCCCGCCGAGCCCCACCCGTTCGAATGCACGGA 
2170 2180 2190 2200 2210 2220 2230 2240 
N C C G C L C C G R 
AAACGGCGGCGGATGCCTGTGCTGCGGGCGCTAGCCCGCAGCATCCATCCGCCCCGCACGAACTCAACCTGATCGTCCCG 
2250 2260 2270 2280 2290 2300 2310 2320 
M K V W N A R N D H L T I N Q W A T R I D E I 
AGGAGTAGACGGTGAAAGTCTGGAACGCCCGAAACGACCATCTCACCATCAATCAATGGGCCACGCGGATCGATGAGATC 
2330 2340 2350 2360 2370 2380 2390 2400 
L E A P D G G E V I Y N V D E N D P R E Y D A I F I G 
CTCGAGGCGCCCGATGGCGGAGAGGTCATCTACAACGTGGACGAGAACGATCCACGCGAATACGACGCCATCTTCATCGG 
2410 2420 2430 2440 2450 2460 2470 2480 
G G A A G R F G S A Y L R A M G G R Q L I V D R W P 
CGGCGGCGCCGCCGGGCGCTTCGGCTCGGCCTATCTGCGCGCCATGGGCGGCCGGCAGCTCATCGTCGACCGCTGGCCGT 
2490 2500 2510 2520 2530 2540 2550 2560 
F L G G S C P H N A C V P H H L F S D C A A E L M L A 
TCCTGGGCGGCTCGTGCCCGCACAATGCGTGCGTGCCGCACCATCTGTTCTCCGACTGCGCGGCCGAGCTGATGCTCGCG 
2570 2580 2590 2600 2610 2620 2630 2640 
R T F S G Q Y W F P D M T E K V V G I K E V V D L F R 
CGCACCTTCTCGGGCCAGTACTGGTTCCCGGACATGACCGAGAAGGTGGTCGGCATCAAGGAGGTGGTCGATCTGTTCCG 
2650 2660 2670 2680 2690 2700 2710 2720 
A G R N G P H G I M N F Q S K E Q L N L E Y I L N C 
CGCCGGGCGCAACGGCCCGCACGGCATCATGAACTTCCAGTCCAAGGAACAGCTCAACCTCGAATACATCCTCAACTGCC 
2730 2740 2750 2760 2770 2780 2790 2800 
P A K V I D N H T V E A A G K V F K A K N L I L A V G 
CGGCCAAGGTGATCGATAATCACACCGTCGAGGCGGCCGGCAAGGTGTTCAAGGCCAAGAACCTGATCCTCGCGGTGGGC 
2810 2820 2830 2840 2850 2860 2870 2880 
A G P G T L D V P G V N A K G V F D H A T L V E E L D 
GCGGGGCCGGGCACGCTCGACGTGCCGGGCGTCAACGCCAAGGGCGTCTTCGACCACGCGACGCTGGTGGAGGAGCTCGA 
2890 2900 2910 2920 2930 2940 2950 2960 
Y E P G S T V V V V G G S K T A V E Y G C F F N A T 
CTACGAGCCCGGCAGCACCGTGGTCGTGGTGGGCGGCTCGAAGACCGCGGTCGAATATGGCTGCTTCTTCAACGCCACCG 
2970 2980 2990 3000 3010 3020 3030 3040 
G R R T V M L V R T E P L K L I K D N E T R A Y V L D 
GCCGGCGCACCGTGATGCTGGTGCGCACCGAGCCGCTCAAGCTCATCAAGGACAACGAGACCCGCGCCTACGTGCTCGAC 
3050 3060 3070 3080 3090 3100 3110 3120 
R M K E Q G M E I I S G S N V T R I E E D A N G R V Q 
CGCATGAAGGAGCAGGGCATGGAGATCATCTCCGGCTCCAACGTCACGCGCATCGAGGAGGACGCCAACGGCCGCGTTCA 
3130 3140 3150 3160 3170 3180 3190 3200 
A V V A M T P N G E M R I E T D F V F L G L G E Q P 
GGCGGTGGTGGCCATGACGCCCAACGGCGAGATGCGCATCGAGACCGACTTCGTCTTCCTCGGCCTCGGCGAGCAGCCCC 
3210 3220 3230 3240 3250 3260 3270 3280 
R S A E L A K I L G L D L G P K G E V L V N E Y L Q T 
GCTCGGCGGAGCTGGCGAAGATCCTGGGCCTCGATCTCGGCCCCAAGGGCGAGGTGCTGGTCAACGAATATCTTCAGACC 
3290 3300 3310 3320 3330 3340 3350 3360 
S V P N V Y A V G D L I G G P M E M F K A R K S G C Y 
AGCGTGCCCAACGTCTACGCGGTGGGCGACCTCATCGGCGGGCCCATGGAGATGTTCAAGGCCCGCAAGTCCGGCTGCTA 
3370 3380 3390 3400 3410 3420 3430 3440 
A A R N V M G E K I S Y T P K N Y P D F L H T H Y E 
TGCCGCGCGCAACGTCATGGGCGAGAAGATCTCCTACACGCCCAAGAATTATCCCGACTTCCTGCACACCCATTACGAGG 
3450 3460 3470 3480 3490 3500 3510 3520 
V S F L G M G E E E A R A A G H E I V T I K M P P D T 
TCAGCTTCCTCGGCATGGGCGAGGAGGAAGCCCGCGCGGCGGGGCACGAGATCGTCACCATCAAGATGCCGCCGGACACG 
3530 3540 3550 3560 3570 3580 3590 3600 
E N G L N V A L P A S D R T M L Y A F G K G T A H M S 
GAGAACGGCCTCAACGTGGCGCTGCCGGCCTCCGACCGCACCATGCTCTACGCCTTCGGCAAGGGCACGGCCCACATGTC 
3610 3620 3630 3640 3650 3660 3670 3680 
G F Q K I V I D A K T R K V L G A H H V G Y G A K D 
GGGCTTCCAGAAGATCGTCATCGACGCCAAGACCCGCAAGGTGCTCGGCGCCCATCACGTGGGCTATGGCGCGAAGGACG 
3690 3700 3710 3720 3730 3740 3750 3760 
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A F Q Y L N V L I K Q G L T V D E L G D M D E L F L N 
CGTTCCAATACCTGAACGTGCTCATCAAGCAGGGGCTCACCGTCGACGAACTGGGGGACATGGACGAATTGTTCCTCAAT 
3770 3780 3790 3800 3810 3820 3830 3840 
P T H F I Q L S R L R A G S K N L V S L M S R V A I V 
CCGACCCACTTCATCCAGCTCTCGCGCCTGCGCGCGGGCTCGAAGAATCTGGTGAGCCTGTQAGCCGCGTCGCCATTGTC 
3850 3860 3870 3880 3890 390T3— 3910 3920 
T G A S S G N G L A I A T R F L A R G D R V A A L D L 
ACCGGCGCCTCGTCGGGCAATGGCCTGGCGATCGCCACGCGCTTCCTGGCGCGTGGCGATCGCGTGGCGGCGCTCGACCT 
3930 3940 3950 3960 3970 3980 3990 4000 
S A E T L E E T A R T H W H A Y A D K V L R V R A D 
TTCCGCCGAGACCCTCGAAGAGACCGCCAGGACCCATTGGCACGCTTATGCCGACAAGGTGCTGCGCGTGCGCGCCGACG 
4010 4020 4030 4040 4050 4060 4070 4080 
V A D E G D V N A A I A A T M E Q F G A I D V L V N N 
TGGCGGACGAAGGCGACGTCAACGCCGCGATCGCCGCGACCATGGAGCAGTTCGGCGCCATCGACGTGCTCGTCAACAAT 
4090 4100 4110 4120 4130 4140 4150 4160 
A G I T G N S E A G V L H T T P V E Q F D K V M A V N 
GCCGGCATCACCGGCAACAGCGAGGCGGGCGTCCTGCACACGACGCCCGTCGAGCAGTTCGACAAGGTGATGGCGGTCAA 
4170 4180 4190 4200 4210 4220 4230 4240 
V R G I F L G C R A V L P H M L L Q G A G V I V N I 
TGTGCGCGGCATCTTCCTGGGTTGCCGCGCGGTGCTGCCGCACATGCTGCTGCAGGGCGCCGGCGTCATCGTCAACATCG 
4250 4260 4270 4280 4290 4300 4310 4320 
A S V A S L V A F P G R S A Y T T S K G A V L Q L T K 
CCTCGGTCGCGAGCCTCGTCGCGTTCCCGGGGCGCTCCGCCTACACCACCTCCAAGGGGGCGGTGCTGCAGCTCACGAAG 
4330 4340 4350 4360 4370 4380 4390 4400 
S V A V D Y A G S G I R C N A V C P G M I E T P M T Q 
TCCGTGGCGGTGGACTATGCCGGCTCCGGCATCCGCTGCAACGCGGTCTGTCCGGGCATGATCGAGACGCCCATGACCCA 
4410 4420 4430 4440 4450 4460 4470 4480 
W R L D Q P E L R D Q V L A R I P Q K E I G T A A Q 
GTGGCGCCTCGACCAGCCGGAGCTGCGCGACCAGGTCCTCGCCCGCATCCCGCAAAAGGAGATCGGCACGGCCGCCCAGG 
4490 4500 4510 4520 4530 4540 4550 4560 
V A D A V M F L A G E D A T Y V N G A A L V M D G A Y 
TGGCGGACGCGGTGATGTTCCTGGCGGGCGAGGACGCAACCTACGTCAACGGCGCCGCGCTGGTGATGGATGGCGCTTAC 
4570 4580 4590 4600 4610 4620 4630 4640 
T A I m l d a e v i 
ACCGCCATCTGATCTTGCGCGCCGCCCCGAGCAGAAAGGCAGGACGAAGGTGACCGGCATQCTGGACGCAGAGGTCATCG 
4650 4660 4670 4680 4690 47TTT)- 4710 4720 
a i t g g a a g i g l a v a h a a i r a g a r v a l i 
CCATCACGGGGGGCGCCGCCGGCATCGGGCTGGCGGTGGCCCACGCGGCCATAAGGGCCGGCGCGAGGGTGGCGCTCATC 
4730 4740 4750 4760 4770 4780 4790 4800 
d r d g a c a q r a a a 
GATCGTGACGGCGCTTGCGCCCAACGGGCGGCGGCCG 
4810 4820 4830 
Fig. 4. Nucleotide sequence of the 4.8 kb EcoRI/H/ndlll fragment complementing 
Xanthobacter Py2M10 mutant deficient in epoxyalkane-degrading activity and the deduced 
amino acid sequence of the four open reading frames. The open reading frames are: ORF1: 
875-2002; ORF2: 2074-2271; ORF3: 2332-3900; ORF4: 3900-4649. The start codon of 
each open reading frame is printed in bold. The nucleotide sequence is presented from the 
H/ndlll to the EcoRI site. The EMBL accession number for this sequence is X79863. 
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A novel type of pyridine 
nucleotide-disulfide 
oxidoreductase is essential for 
NAD+- and NADPH-dependent 
degradation of epoxyalkanes by 
Xanthobacter strain Py2 
Jelto Swaving, Jan A.M. de Bont, Adri Westphal 
and Aart de Kok 
Epoxide degradation in cell extracts of Xanthobacter strain Py2 
has been reported to be dependent on NAD+ and dithiols. This 
multicomponent system has now been fractionated. A key 
protein encoded by a DNA fragment complementing a 
Xanthobacter strain Py2 mutant unable to degrade epoxides was 
purified and analyzed. This NADP dependent protein, a novel 
type of pyridine nucleotide-disulfide oxidoreductase, is essential 
for epoxide degradation. NADPH, acting as the physiological 
cofactor replaced the dithiols in epoxide conversion. 
Introduction 
Propene grown Xanthobacter strain Py2 (Van Ginkel & De Bont, 1986) 
contains an enzyme system capable of degrading epoxyalkanes, which are 
metabolites arising from alkenes by the action of alkene monooxygenase. 
Recently, both the monooxygenase (Zhou et al, 1996) and the epoxide-
degrading system of the organism have received considerable attention. 
Initially, this interest was based on applied aspects because the organism 
may be used in the degradation of chlorinated alkenes and epoxides 
(Ensign et al. 1992, Reij et al., 1995, Small et al, 1995, Ensign, 1996) 
and in the production of optically pure epoxides (Weijers et al, 1988). As 
it turns out the epoxide-degrading enzyme system has very intriguing 
properties and was therefore investigated in detail. 
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Initially, epoxide degradation was studied at the whole cell level (Weijers 
et al., 1988, Small & Ensign, 1995). Recently, Weijers, et al. (1995) were 
able to demonstrate enzyme activity in extracts if both NAD and a low-
molecular-mass fraction were included in the assay system. Furthermore, 
they showed that a range of artificial dithiol compounds, such as 
dithiothreitol (DTT) can replace the low-molecular-mass fraction. Ketones 
were the product formed under their assay conditions. Allen and Ensign 
(1996) also studied the fate of epoxides in extracts. They included 
carbonate in their assay system and proposed that the enzyme system of 
Xanthobacter strain Py2 carboxylated 1,2-epoxyalkanes to form B-keto 
acids. In their view, ketones are dead end products, which are formed only 
when carbonate is limiting. The formation for either product from an 
epoxide is redox neutral. The requirement of both NAD and a dithiol 
therefore suggests that reduction of the epoxide is followed by oxidation 
or vice versa. 
The first report of a successful fractionation of the epoxide-degrading 
enzyme system was by Leak and coworkers (Imperial College, London, 
United Kingdom). They were able to devise a method resulting in two 
fractions, both of which were required to reconstitute an active epoxide-
degrading system (Vassaroti et al, 1995). 
Swaving et al. (1995) reported the cloning of a 4.8 kb DNA fragment 
required for complementation of mutants of Xanthobacter strain Py2 
defective in epoxide degradation. From the deduced amino acid sequences 
of the four open reading frames of this fragment no clear information on 
how the degradation of epoxides proceed could be gained. However, the 
protein encoded by ORF3 was of great interest because of its homology to 
the family of pyridine nucleotide-disulfide oxidoreductases (Williams, 
1992). The homology was of special interest because most members of 
this family use dithiols as a substrate, whereas dithiols replaced low-
molecular-mass fraction in the epoxide-degrading assay (Weijers et al, 
1995). 
In the present paper we present a comparison of the amino acid sequence 
of the ORF3 protein with these of other important proteins from the 
family of pyridine nucleotide-disulfide oxidoreductases. This comparison 
led us to test for the involvement of NADPH in the epoxide-degrading 
reaction. This involvement was confirmed by using cell extracts as well as 
purified ORF3 protein. 
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. .+ . ++.+ .. ~ ~. . . . . . . + + .X . .-1.+ . . . . . 
X.QRF3 DPREYDAIFIGGGAAGRFGSAYLRAMGGRQLIVDRW PFLGGSCPHNACVPHHLFSDCAAELMLARTFSG 108 
MR.BA GNYDYDYIIIGSGGAAFSSAIEAVALNAKVAMIER GTVGGTCVNVGCVPSKTLLRAG-EINHLAKNNP 232 
LD.AZ MSQKFDVIVIGAGPGGYVAAIKSAQLGLKTALIEKYKGKEGKTALGGTCLNVGCIPSKALLDSSYKFHEAHESFK 75 
GR.HU AVASYDYLVIGGGSGGLASARRAAELGARAAWESHK LGGTCVNVGCVPKKVMWNTAVHSEFMHDHAD 83 
X.ORF3 QYWFPDMTEKV VGIKFAA/DLFRAGRNGPHGIMNFQSKEQLNLEYII^CPAKVIDNHTVFJ^GKVFKAKNLIL 180 
MR.BA FVGLHTSASNVDIAPLVKQKiroLVTEMRraiCYVNLIDDYGFELIKGESKFVNENTVEVNGNQ ITAKRFLI 302 
LD.AZ LHGISTGFA/AIDVPTMIARKI^IVRNLTGGV-ASLIKANGVTLFEGHGKLLAGKKVEVTAADGSSQVLDTENVIL 149 
GR.HU Y-GFPSCEGKFNWRVIKEKRDAYVSRL-NAIYQNNLTKSHIEIIRGHAAFTSDPKPTI EVSGKKYTAPHILI 154 
X.ORF3 AVGAGPGTLDVPGVNAKGVFDHATLVEELDYEPGSTVVVVGGSKTAVEYGCFFNATGRRTVMLVRTEPLKLIKDN 255 
MR.BA ATGASSTAPNIPGLDEVDY-LTSTSLLELKKVPNR-LTVIGSGYIGMELGQLFHNLGSEVTLIQRSERLLKEYDP 375 
LD.AZ ASGSKPVEIPPAPVDQDVI-VDSTGAIXIFQNVPGK-1X3VIGAGVIGLELGSVWARLGAEVTVLEAMDKFLPAVDE 222 
GR.HU ATGGMPSTPHESQIPGASLGITSDGFFQLEELPGR-SVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDS 228 
+ +. + + .+ 
X.ORF3 ETRAYVLDRMKEQGMEIISGSNVTRIEEDANGRVQAWAMTPNG EMRIETDFVFLGLGEQPRSAELA-KIL 325 
MR.BA EISEAITKALTEQGINLVTGATYERVE-QDGDIKKVHVEINGKKRII EAEQLLIATGRKPIQTSLNLHAA 444 
LD.AZ QVAKEAQKILTKQGLKILLGARVTGTEVKNKQVTVKFVDAEGEKSQ AFDKLIVAVGRRPVTTDLLAADS 291 
GR.HU MISTNCTEELEl^GVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKL 303 
+ . . . + +. . + . + + . + . .. . . . . +. 
X.ORF3 GLDLGPKGEVLVNEYLQTSVPNVYAVGDLIGGPMEMFKARKSGCYAARNVMGEKISYTPKNY PDFLHTHYEV 397 
MR.BA GVEVGSRGEIVIDDYLKTTNSRIYSAGDVTPGPQFVYVAAYEGGIAARNAIGGLNQ--KVNLEVVPGVTFTSPSI 517 
LD.AZ GVTLDERGFIYVDDYCATSVPGVYAIGDWRGAMLAHKAS-EEGVWAERIAGHKA--QMNYDLIPAVIYTHPEI 363 
GR.HU GIQTDDKGHIIVDEFQMm^GIYAVGDVC-GKALLTPVAIAAGRKIAHRLFEYKEDSKLDYNNIPTVVFSHPPI 377 
X.QRF3 SFLGMGEEEARAAGHEIVTIKMPPDTENGLNVALPASDRTMLYAFGKGTAHMSGFQKIVIDAKTRKVLGAHHVGY 472 
MR.BA ATVGLTEQQAKEK—GYE-VKTSV LPLDAVPRALV NRETTGVFKLVADAKTLKVLGAHWAE 576 
LD.AZ AGVGKTEQALKAE—GVA-INVGV FPFAASGRAMA ANDTAGFVKVIADAKTDRVLGVHVIGP 422 
GR.HU GTVGLTEDEAIHK-YGIENVKTYS TSFTPMYHAVT KRKTKCVMKMVCANKEEKWGIHMQGL 438 
. . . . + . . . . . . . . + 
X.ORF3 GAKDAFQYLNVLIKQGLTVDELGDMDELFLNPTHFIQLSRLRAGSKNLVSL 523 
MR.BA NAGDVIYAATIJWKFGLTVGDLRETMAPYLTMAEGLKLAVL-TFDKDVSKLSCCAG 631 
LD.AZ SAAELVQQGAIAMEFGTSAEDLGMMVFAHPALSEALHEAAL-AVSGHAIHVANRKK 477 
GR.HU GCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEEL—VTLR 478 
Fig. 1. Alignment of the Xanthobacterstrain Py2 ORF3 protein amino acid sequence (X. ORF3) 
to mercuric reductase (MR.BA) of Bacillussp. RC607 (Wang era/., 1989), dihydrolipoamide 
dehydrogenase (LD.AZ) of Azotobacter vinelandii (Westphal & De Kok, 1988), and humane 
glutathione reductase (GR.HU) (Tutic era/., 1990). For the latter three proteins, the three-
dimensional structures are known (Schiering et al. 1991, Mattevi et al. 1991, Karplus & Schultz, 
1989). Site of interest are underlined (see text). Amino acids identical in all the species are 
indicated with a plus; similar amino acids with a dot; and gaps in the sequences are indicated 
by clashes. The two cysteines of the redox-active disulfide bridge are indicated with arrows. The 
N terminal sequence of the ORF3 protein starts at position 39. 
AMINO ACID SEQUENCE ANAL YSIS OF THE ORF3 PROTEIN 
The pyridine nucleotide-disulfide oxidoreductases are a class of enzymes 
with a consensus primary structure (Williams, 1992) consisting of the 
nucleotide binding site of flavin adenine dinucleotide (FAD) (Wierenga et 
al, 1986) at the N terminus followed by the redox-active disulfide bridge 
(Williams, 1992), the nucleotide binding site of NAD(P) (Wierenga et al, 
1986), and the ribityl moiety of the FAD (Eggink et al., 1990) followed by 
either an active site His-Glu dyad or a cysteine pair (mercuric reductase) 
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Enzyme 
DLDH_ACHLA 
DLDH_AZOVI 
DLDH_BACSU 
DLDH_BACST 
0RF3 
MERA_BACSR 
MERA_STAAU 
GSHR_PSEAE 
GSHR_PEA 
Amino acid seg^ience 
VIVGGGVIGVEFATVFNSFGSKVTIIEMMDGILPTMDDD 
GVIGAGVIGLELGSVWARLGAEVTVLEAMDKFLPAVDEQ 
WIGGGYIGTELGTAYANFGTELVILEGGDEILPGFEKQ 
WIGGGYIGIELGTAYANFGTKVTILEGAGEILSGFEKQ 
VWGGSKTAVEYGCFFNATGRRTVMLVRTEPLKLIKDNE 
TVIGSGYIGMELGQLFHNLGSEVTLIQRSERLLKEYDPE 
AVIGSGYIAAELGQMFHNLGTEVTLMQRSERLFKTYDPE 
LWGGGYIAVEFASIFNGLGAETTLLYRRDLFLRGFDRS 
AIVGGGYIALEFAGIFNGLKSEVHVFIRQKKVLRGFDEE 
Position 
215 
223 
218 
218 
256 
376 
292 
208 
288 
Fig. 2. Comparison of the binding sites of the ADP parts of the NAD- and NADP-dependent 
pyridine nucleotide-disulfide oxidoreductases. The dihydrolipoamide dehydrogenases 
(accession numbers with DLDH) are NAD dependent; the mercuric reductases (MERA) and 
glutathione reductases (GSHR) are NADP-dependent. For details, see text. E, conserved 
Glu residue; R, Arg forming a salt bridge with the 2' phosphate moiety. The other residues in 
bold represent the conserved pap-fold of NAD(P)-specific enzymes. 
at the C terminus (Williams, 1992). In Fig. 1, the ORF3 protein sequence 
is aligned with those of a mercuric reductase, a glutathione reductase, and 
a dihydrolipoamide dehydrogenase with known three-dimensional 
structures. With the exception of the His-Glu dyad or the C terminal 
cysteine pair, all above-mentioned features are conserved, indicating that 
the ORF3 protein belongs to the class of pyridine nucleotide-disulfide 
oxidoreductases. 
The pyridine nucleotide binding motifs for NAD and NADP specific 
enzymes show some characteristic differences (Fig. 2) next to the 
conserved (3a|3-fold (Wierenga et al, 1986). The motif for NAD 
(dihydrolipoamide dehydrogenases) has a conserved Glu (Fig. 2) that 
forms a H bridge with the 2' and 3' OH of ribose. In the NADP-dependent 
enzymes (glutathione reductase and mercuric reductase) this Glu is no 
longer conserved and an arginine forms a salt bridge with the 2' phosphate 
moiety (Karplus & Schultz, 1989). A nearby Arg or Lys is also involved 
in the interaction. On the basis of these differences, the sequence data 
strongly suggest that ORF3 encodes an NADP-dependent protein. 
THE ORF3 PROTEIN IS INVOLVED IN EPOXIDE DEGRADATION 
To establish whether the ORF3 protein is involved in epoxide degradation 
we decided to purify the protein by using the diaphorase activity assay 
(Straub, 1939) with NADPH as the electron donor and dichlorophenol-
indophenol as the acceptor. The ORF3 protein was purified from wild-
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Table 1. The specific 1,2-epoxypropane degrading activities in fractionated extracts of 
Xanthobacter strain Py2a. 
Protein fraction 
crude extract 
second peak from gel-filtration 
HICyeiiow + HICrest 
flll^ yellow 
HICrest 
purified ORF3 protein 
purified ORF3 + HICrest 
Specific activity 
14 
6 
6 
<1 
1 
0 
10b 
The specific activities (in nanomols of 1,2-epoxypropane degraded per minute per milligram of 
protein) were determined by adding 2 mg of protein from each fraction to a 30-ml serum bottle 
in a total volume of 300ul 1,2-Epoxypropane (1 mM), NAD+ (2 mM), and KHCO3 (50 mM) 
were added and the reaction was started by adding NADPH (2 mM). The assay was performed 
by measuring the consumption of 1,2-epoxypropane by headspace analysis using gas 
chromatography as described before (Weijers etal, 1995). 
Although equal amounts of purified ORF3 protein and HICyen0W were added, the purified 
ORF3 contained twice as much FAD-protein as the HICyenow fraction as judged from the A450 of 
FAD, which might explain the higher specific activity as observed in HICyeiiow + HICrest- Under 
the assay conditions used here the amount of ORF3 protein seems to be rate limiting for the 
epoxide degrading activity. 
type Xanthobacter strain Py2 grown on propene, according to the 
procedure used for dihydrolipoamide dehydrogenase (Swaving, 
unpublished data, Westphal & De Kok, 1988). Ion-exchange 
chromatography on a HiLoad Q-Sepharose column (Pharmacia) was 
performed as an additional step in the purification. The specific activity 
with dichlorophenol-indophenol as the acceptor was 2.7 U mg . The N-
terminal sequence (performed by Eurosequence, Groningen, The 
Netherlands) of the ORF3 protein, Met-Lys-Val-Trp-Asn-Ala-Arg, 
matched the DNA-derived amino acid sequence exactly. 
Next, an extract without the ORF3 protein was prepared. A crude extract 
of propene-grown Xanthobacter strain Py2 cells was prepared (Weijers et 
al, 1995) and 5 ml (25 mg of protein per ml) was loaded onto a 75-cm 
Sephacryl S-300 (Pharmacia) gel filtration column and was eluted with a 
20 mM EPPS (N-[2-hydroxyethyl]piperazine-N'-[3-propanesulfonic 
acid]) buffer, pH 8.0 (0.75 ml/min). The chromatogram showed two major 
peaks, and epoxide-degrading activity was found in the second peak 
(yellow). To this second fraction (NH^SC^ was added to a final 
concentration of 1 M. The second fraction was then loaded onto a phenyl 
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Superose 5/5HR hydrophobic interaction column (Pharmacia) for fast 
protein liquid chromatography (FPLC) and the proteins were eluted with a 
0.7 to 0 M (NH4)2S04 buffered (20 mM EPPS, pH 8.0) gradient (0.5 
ml/min, 15-ml elution volume). One major yellow peak (the only one) 
was eluted at an early stage. A fraction containing this yellow peak, 
designated HICyenow was separated from the rest fractions (HICrest). Both 
fractions were concentrated to 1.0 ml with the Amicon Centriprep 3 
system and were washed several times with EPPS buffer to remove the 
(NH^SO/j. Although the combined fractions did restore 1,2-
epoxypropane-degrading activity completely, no activity was measured in 
either of the fractions. The purified ORF3 protein combined with the 
HICrest fraction could restore activity (Table 1), clearly demonstrating that 
the ORF3 protein is essential in the epoxide-degrading system of 
Xanthobacter strain Py2. 
THE ROLE OF NADPH IN EPOXIDE DEGRADA TION 
From both the amino acid sequence analysis and the ORF3 protein 
purification, it was established that NADP is the cofactor for ORF3. Up to 
the time of present study, the influence of NADP on epoxide-degrading 
activity had been tested only by replacing NAD+ in the reaction (Weijers 
et al, 1995); little or no effect was found. The effect of NADP and other 
(co)factors on specific epoxide-degrading activity was therefore 
investigated in more detail (Table 2). A dialyzed crude extract from 
propene-grown cells was prepared and the activity assay was performed as 
described before (Weijers et al, 1995). The addition of 50 mM KHCO3 
has a positive effect on epoxide-degrading activity, as was shown before 
(Allen & Ensign, 1996). NAD, NADPH, or DTT alone did not restore 
activity. The most interesting result from these experiments is, however, 
that the artificial cofactor DTT can be replaced by the physiologically 
relevant cofactor NADPH. These results strongly suggest that NADPH is 
the true physiological cofactor for epoxide degradation. 
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Table 2. Effects of NAD+, NADPH, DTT, and C02 on the rate of degradation of 1,2-
epoxypropane by dialyzed extract of Xanthobacter strain Py2 
(co)factors used 
none 
NAD+ 
NADPH 
DTT 
KHCO3 
NAD+ + DTT 
NAD+ + KHCO3 + 
NAD+ + NADH 
NAD+ + NADPH 
NAD+ + KHCO3 + 
DTT 
NADPH 
relative activity (%) 
3 
5 
12 
15 
6 
100 
180 
5 
55 
95 
a
 The concentrations of the compounds used were as follows: NAD and NADPH, 2 mM; DTT, 
10 mM; and KHCO3, 50 mM. Rates were determined by adding 1,2-epoxypropane (1 mM) to 
extracts; the compounds were subsequently added. 
The rate of 1,2-epoxypropane degradation after adding the combination of NAD+ and DTT 
was taken as 100%.The observation that dithiols can be replaced by NADPH can be explained 
by the nature of the ORF3 protein. Both NADPH and DTT are able to reduce the redox-active 
disulfide bridge of the ORF3 protein. NADPH donates electrons via the FAD, whereas DTT 
directly reduces the active site disulfide bridge. 
The ORF3 protein described here is the first protein identified as being 
involved in the complex degradation of epoxides by Xanthobacter strain 
Py2. At the same time the results show that at least one other protein is 
required for epoxide conversion. For now, we can only speculate on the 
true nature of the ORF3 protein. Whether it acts directly on the epoxide or 
passes on its reducing equivalents to other proteins remains a subject for 
future research. 
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Purification and 
characterization of a 
flavoprotein involved in the 
degradation of epoxyalkanes by 
Xanthobacter Py2 
Adrie H. Westphal, Jelto Swaving, Linda 
Jacobs and Aart de Kok 
Spectroscopic and stopped flow experiments involving 
reduction by NADPH show three phases: rapid reduction of the 
flavin and formation of the reduced flavin-NADP* charge-transfer 
complex, followed by the slow formation of the charge-transfer 
complex between flavin and disulfide and finally very slow 
further reduction and redistribution of reducing equivalents. 
Photoreduction in the presence of deazaflavin also results in 
rapid reduction of the FAD followed by a slow formation of a 
stable semiquinone. Full reduction could not be achieved by 
photoreduction or with NADPH and was incomplete even with 
dithionite or NADPH in the presence of arsenite. The results 
indicate component II to shuttle between the oxidized and the 
two electron reduced state. 
Steady state kinetic studies using the artificial substrate 1,3-
propanedithiol show component II to have a ternary complex 
mechanism in the direction of NADP+ reduction. 
The active site base, a histidine, which is normally present in 
lipoamide dehydrogenase and glutathione reductase, is 
replaced by an asparagine. The effects on catalysis, decreased 
activation of the dithiol substrate and a greatly diminished rate 
of electron transfer from FAD to the dithiol, are similar to 
mutants of lipoamide dehydrogenase in which the histidine is 
replaced by other residues. 
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Introduction 
The Xanthobacter Py2 (Van Ginkel & De Bont, 1986) contains an 
intriguing enzyme system capable of degrading epoxyalkanes which are 
metabolites arising from alkenes by the action of alkene monooxygenase 
(Weijers et al., 1988). In whole cells (Small & Ensign, 1995) and in crude 
extracts (Allen & Ensign, 1996) it was demonstrated that the 
epoxyalkanes are carboxylated to P-keto acids. For this bioconversion 
several (co)factors are necessary. It was first thought the reaction was 
dependent on both NAD+ and a low molecular mass fraction, which could 
be replaced by dithiol compounds like 1,3-propanedithiol and 
dithiothreitol (Weijers et al., 1995). Later it was shown that the reaction is 
dependent on both NADPH and NAD+ (Swaving et al., 1996). 
Swaving et al. (1995) reported the cloning of a 4.8 kb DNA fragment 
required for complementation of mutants of Xanthobacter strain Py2 
defective in epoxide degradation. This fragment contained four open 
reading frames. The protein encoded by orfl shows weak similarity with 
cobalamin independent methionine synthase (EC 2.1.1.14). It contains the 
motif DCGL, which was implicated in Zn binding (Gonzalez et al, 1997). 
The protein, named component I, was shown to be involved in the 
degradation of epoxides (Chan Kwo Chion & Leak, 1996; Swaving et al., 
1996, Allen and Ensign, 1997b). Orfl encodes a 7.4 kDa protein that 
shows similarity with rubredoxin 2 from Pseudomonas oleovorans. 
Interestingly, all 8 cysteines are conserved. This protein has as yet not 
been identified or implicated in epoxide degradation. The orf3 encoded 
protein showed significant similarity with pyridine nucleotide-disulfide 
oxidoreductases (Swaving et al., 1996). This orfl encoded protein, named 
component II and shown, as is the case with component I, to be involved 
in epoxide degradation. Recently two other highly homologous proteins, 
component III and IV, were described as being required to functionally 
reconstitute the epoxide degradation system (Allen & Ensign, 1997a,b). 
These proteins are encoded respectively by or/4 on the original 4.8 kb 
DNA fragment and or/5 located on a additional 2.2 kb DNA fragment, 
also sequenced by Swaving et al (1995). Sofar no evidence has been 
obtained for a physical association of these enzymes into a multi enzyme 
complex. According to Allen and Ensign (1997a) the overall pathway 
might be visualized as indicated in Fig. 1. Component I has been 
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F/gL 1. A hypothetical scheme for the conversion of 1,2 propane epoxide to acetoacetate by 
Xanthobacter Py2, based on Allen and Ensign (1997a), indicating the role that component II 
might play in the conversion. The origin of the redox active disulfide moiety is unknown. 
identified by Allen and Ensign (1997) as the epoxide binding protein by 
using the inhibitor methylepoxypropane. The identity of the disulfide 
substrate is at present unknown. It could be the orfl-encoded protein, 
component II or a disulfide located on any of the other enzymes. 
Although the sequence identity of component II with known disulfide 
oxidoreductases is low (19% similarity with the mercuric reductase of 
Bacillus), similarity is found within all four domains. Interesting 
differences with existing disulfide reductases are found, most striking is 
the observation that the C-terminal active site His is replaced by Asn 
(Swaving et al., 1996). 
To obtain more insight in the complex degradation of epoxides by the 
Xanthobacter Py2 and to unravel the role of this new type disulfide 
oxidoreductase, component II was purified and characterized. 
Materials and Methods 
MATERIALS 
NAD(P)H and NAD(P)+ were from Boehringer. Lipoamide, 2,6-
dichlorophenolindophenol (Chlnd), 5,5'-dithiofow(2-nitrobenzoate) 
(Nbs2), 1,3-propanedithiol, reduced glutathione and biological buffers 
were from Sigma Inc. Oxidized glutathione was from Janssen Chimica. 
Reduced lipoamide was prepared from lipoamide by reduction with 
borohydride (Reed et al, 1958). Deaza riboflavin was a gift from Dr S.G. 
Mayhew (Dublin, Ireland). HiLoad Q-Sepharose, Sephacryl S400 and 
Superdex 200 were from Pharmacia (Uppsala, Sweden). Lipoamide 
dehydrogenase was isolated from Azotobacter vinelandii as described 
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previously (Westphal and De Kok, 1988) and glutathione reductase from 
Escherichia coli was a gift from mrs. P.A.W van den Berg. 
ANALYTICAL METHODS 
All activity assays were performed in 50 mM sodium pyrophosphate , pH 
8.0 containing 1 mM EDTA (buffer A) at 25 °C, except for the steady-
state kinetics which were performed in 50 mM EPPS (N-[2-
hydroxyethyl]piperazine-N' -[3-propanesulfonicacid]) buffer 
supplemented with 1 mM EDTA, pH 8.5. The concentration of NAD(P)H 
and NAD(P)+ was 0.15 mM unless stated otherwise. The reaction with 
reduced or oxidized lipoamide, reduced or oxidized glutathione as well as 
the oxidation of aliphatic dithiols, 0.75 mM final concentration (e.g. 1,3-
propanedithiol), was assayed spectrophotometrically following the 
NAD(P)H concentration at 340 nm. The reduction of Nbs2 (0.75 mM) was 
followed at 412 nm and the reduction of Cl2Ind (0.45 mM) at 600 nm. The 
final volume was 1 ml. The reaction was started by the addition of the 
enzyme. Each cuvette contained 41 pmol enzyme (monomer). With the 
physiological substrate, 4.1 pmol was used. 
The FAD determination was done according to Wassink & Mayhew 
(1975). Routinely, the FAD concentration was determined 
spectrophotometrically by using an extinction coefficient at 465 nm of 
11300. 
To determine the pH optimum of component II, the Nbs2 activity was 
assayed using different buffer systems at different pH's. The conductivity 
for all buffers used was adjusted to 5 mS with KC1. The molar extinction 
coefficient of 5-thio 2-nitrobenzoate is dependent on the pH (pH 5.5 -
11800 M"1 cm"1; pH 6.0 - 13000 M"1 cm"1; pH 6.5 - 13200 M"1 cm"1; pH 
7.0 to pH 10.5 - 13600 M"1 cm"1). 
PROTEIN PURIFICATION 
Wild type Xanthobacter Py2 was cultivated in 6 1 mineral medium with 
propene as sole carbon source to induce the epoxyalkane degrading 
enzymes as described before (Swaving et al., 1995). Cells were harvested 
(10 min, 12,000 g, 4°C), washed in 50 mM potassium phosphate pH 7.0 
and resuspended in 30 ml of the same buffer, containing 0.1 mM 
phenylmethanesulfonylfluoride (buffer B). Crude extract was obtained 
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after passage of the cells through a French Press. The extract was clarified 
by centrifugation (45 min, 27,000 g, 4°C). The pellet was resupended in 
20 ml buffer B and again disrupted using the French press and centrifuged 
at the same speed. Both supernatants were pooled and protamine sulfate 
was added to a concentration of 6 mg/ml and the solution was clarified by 
centrifugation at 27,000 g.. 
Ammonium sulfate was added to the supernatant to 40 % saturation and 
the solution was clarified by centrifugation at 27,000 g for 30 min. 
Ammonium sulfate was further added to 60 % saturation and the resulting 
precipitate was recovered by centrifugation at 27,000 g for 30 min. The 
pellet was dissolved in 35 ml 25 mM EPPS pH 8.0, 0.5 mM EDTA and 
0.1 mM phenylmethanesulfonylfluoride. 
The protein solution was applied to a 60 ml HiLoad Q-Sepharose column 
and eluted using a 0.0 - 0.5 M KC1 gradient in the EPPS buffer. Active 
fractions were pooled, and concentrated to 5.4 ml using an Amicon YM 
30 system. Finally the protein solution was applied to a Sephacryl S400 
(2.5 x 100 cm) column and eluted using the EPPS-buffer containing 150 
mM KC1. Active fractions were analyzed on SDS-PAGE and the purest 
fractions were pooled and concentrated to 4.5 ml. 
ANALYTICAL METHODS 
SDS-PAGE was performed as described by Laemmli (1970). Protein 
concentrations were estimated by the microbiuret method (Goa, 1953). 
Bovine serum albumin was used as a standard. 
The native molecular weight was determined using a Superdex 200 
column. The column was equilibrated using 20 mM potassium phosphate 
pH 7.0, containing 150 mM KC1 and 0.5 mM EDTA. Marker proteins 
were run in parallel (catalase, 240 kDa, dihydrolipoamide dehydrogenase 
from Azotobacter vinelandii, 100 kDa, and ovalbumine, 45 kDa). 
Eurosequence (Groningen, The Netherlands) carried out N-terminal 
sequence determination. 
Absorption spectra were recorded with a Perkin Elmer 550S 
spectrophotometer or with a HP 8453 diode array spectrophotometer. 
Enzyme solutions were made anaerobic by alternate evacuation and 
flushing with oxygen free argon. The cuvette was equipped with a side 
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arm that contained 1.5 |iM 5'-deaza riboflavin, 1 mM methylviologen and 
15 mM EDTA. The methylviologen was photo-reduced by irradiation 
with a 150 W Fi-L151 projector (Fiberoptic Heim AG) equipped with a 
fiberglass cable. 
Photo-reduction of component II was carried out by stepwise illumination 
using a 150 W slide projector. The cuvette contained 50 mM EPPS pH 
8.5, 10% glycerol, 15 mM EDTA, 1.5 uM 5-deaza-riboflavin and 40 uM 
component II. 
Photo-reduction of component II was carried out by stepwise illumination 
using a 150 W slide projector. The cuvette contained 50 mM EPPS pH 
8.5, 10% glycerol, 15 mM EDTA, 1.5 uM 5-deaza-riboflavin and 40 uM 
component II. 
Rapid reaction kinetics were carried out at 25° C using a temperature-
controlled single wavelength stopped-flow spectrophotometer from High 
Tech Scientific Inc., type SF-51 with 1.3 ms dead time. The instrument 
was interfaced to an IBM computer for data acquisition and analysis. Data 
were analyzed with a program from High Tech Scientific Inc. One syringe 
contained 20 uM component II in buffer A, the other 40 U.M NADPH in 
H2O. Solutions were made anaerobic by repeated flushing with oxygen-
free argon. In the spectral titrations with NADPH or dithionite, the 
stoichiometry is expressed as molar equivalents with respect to the flavin 
content. 
Table 1. Purification procedure of component II. Contaminating activities of NAD-dependent 
enzymes (e.g. lipoamide dehydrogenase) were measured during purification of component II. 
Purification step 
Crude extract 
Protamine sulfate 
(NH4)2S04 
HiLoad Sepharose Q 
Sephacryl S400 
Volume 
(ml) 
86 
133 
35.4 
5.4 
4.5 
Protein 
(nig) 
830 
321 
176 
72 
63 
Specific activity (U/mg) 
NADPH/ NADH/ 
Nbs2 
0.32 
0.74 
1.06 
2.04 
2.21 
Nbs2 
0.031 
0.012 
0.005 
0 
0 
NADH/ 
LipS2 
0.91 
0.46 
0.30 
0.02 
0 
NAD/ 
Lip(SH)2 
2.68 
1.86 
0.92 
0.08 
0 
Total activity 
(U) NADPH/ 
Nbs2 
265 
238 
187 
146 
140 
Yield 
(%) 
100 
90 
71 
55 
53 
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Results 
ENZYME PURIFICATION 
Component II was purified from wild type Xanthobacter Py2 grown on 
propene as sole carbon source to induce the epoxyalkane degrading 
proteins as described in the Materials and Methods section. The 
physiological disulfide substrate of the enzyme is not known, therefore, 
the protein was assayed using a general electron acceptor (Nbs2) specific 
for the dithiol group of pyridine nucleotide-disulfide oxidoreductases 
(Ohnishi et al, 1995). In Table 1 the purification scheme is given. The 
purification factor of 6.9 is comparable to that of Allen and Ensign 
(1997a), 5.7. The difference may be due to differences in the assay 
procedure, in the latter case based on reconstitution of epoxide 
carboxylase activity. Harsh procedures, such as a heat treatment, were 
omitted in this procedure. The overall yield was 53%, compared to 32% as 
obtained by Allen and Ensign (1997a). 
From Fig. 2 it is clear that component II is the most abundant protein 
present in crude extracts of propene grown Xanthobacter Py2. The other 
major band of around 41 kDa represents component I, which is proposed 
to be also involved in epoxyalkane degradation (Chan Kwo Chion and 
Fig. 2. Purification of 
component II from 
Xanthobacter Py2 as 
followed on a 10% 
Tricine/SDS-PAGE. 
Lane 1, crude extract; 
lane 2, protamine 
sulfate precipitation 
pool; lane 3, 
(NH4)2S04 
precipitation pool; lane 
4 HiLoad Sepharose 
Q pool, lane 5 the 
Sephacryl S400 pool; 
last lane, marker 
proteins (kDa). 
1 2 3 4 5 
tart 
— • * 
«H) 
fe* 
M 
* 
94 
67 
43 
30 
20.1 
14.4 
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Leak, 1996, Allen and Ensign, 1997a,b). To ensure that the purified 
component II protein is not contaminated with dihydrolipoamide 
dehydrogenase, Table 1 shows the specific activities of dihydrolipoamide 
dehydrogenase and the NADH-dependent Nbs2 activity. Table 1 also 
demonstrates that component II is completely dependent on NADPH. 
The identification of the purified enzyme with component II was carried 
out by the determination of the N-terminal sequence. This sequence 
MKVWNAR matched the DNA-derived sequence exactly (Swaving et al., 
1995). 
PROPERTIES OF THE COMPONENT II 
The enzyme has a bell-shaped pH optimum at pH 8.5 when using Nbs2 as 
the electron acceptor. This value is consistent with the observation of 
Weijers et al. (1995), who found the pH-optimum of epoxyalkane 
degradation in crude extracts to be around pH 8.2. 
Based on the elution pattern of the Superdex 200 column the apparent 
native molecular mass of the protein is 116 kDa (data not shown). From 
the sequence it is known that the subunit molecular weight is 57.3 kDa, 
therefore component II is apparently a homodimeric protein, as are all 
other members of the family of pyridine nucleotide-disulfide 
oxidoreductases (Williams, 1992). The enzyme contains 1 non-covalently 
bound FAD per subunit, as concluded from the molar extinction 
coefficient and FAD content (Wassink & Mayhew, 1975). 
Next to substrates used to measure the diaphorase activity (C^Ind or 
Nbs2) and oxidase activity of component II, several mono and dithiol 
compounds were tested as substrates. Swaving et al. (1996) suggested 
dithiol compounds like dithiothreitol and 1,2-propanedithiol as substrates 
for component II. In Table 2 the specific activities of component II with 
several of these compounds are presented and compared with that of 
lipoamide dehydrogenase and glutathione reductase. No NADPH 
oxidation activity was observed with 1,2-epoxypropane as substrate. 
Preincubation with this compound did not inhibit the activity. Therefore a 
direct interaction with epoxypropane is unlikely. As shown in Table 2 all 
activities tested are lower compared to lipoamide dehydrogenase and 
glutathione reductase with the exception of the NADPH/Nbs2 activity. 
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Table 2. Substrate specificity of component II, compared to lipoamide dehydrogenase and 
glutathione reductase. All assays were carried out in buffer A at 25°C as described in Materials 
and Methods. NADP(H) was used as a substrate for component II and glutathione reductase, 
while NAD(H) was used as a substrate for lipoamide dehydrogenase. 
Substrates 
NAD(P)H/Nbs2 
NAD(P)H/Cl2Ind 
NAD(P)H/02 
NAD(P)H/LipS2 
NAD(P)+/Lip(SH)2 
NAD(P)H/GSSG 
NAD(P)+/GSH 
NAD(P)+ /l ,3-Propanedithiol 
NAD(P)+/Dithiothreitol 
NAD(P)H/1,2-Epoxypropane 
Component II 
U/mg protein 
2.22 
1.04 
0.16 
0 
0.12 
0 
0 
0.23 
0.011 
0 
Specific activity 
Lipoamide 
dehydrogenase 
U/mg protein 
0.18 
38.2 
1.57 
61 
187 
nd 
0 
31.3 
0 
0 
Glutathione 
reductase 
U/mg protein 
0.24 
1.07 
0.034 
0 
0.61 
160.1 
0.48 
0.4 
0 
nd 
The reaction with 1,3-propanedithiol was completely inhibited upon 
incubation of the enzyme for 30 min. with 1 mM N-ethylmaleimide in the 
presence of 0.1 mM NADPH. The NADPH / Nbs2 reaction was also 
completely inhibited, while the NADPH / Cl2Ind activity decreased 94%. 
No inhibition was observed in the absence of NADPH. This indicates that 
the enzyme contains a redox active disulfide group. 
SPECTRAL PROPERTIES OF COMPONENT II 
The purified enzyme has a characteristic flavin spectrum with optima at 
380 and 465 nm and a shoulder at 490 nm. 
Anaerobic stopped flow experiments were performed following the 
change in absorption at 465 nm and 700 nm with 1 molar equivalent 
NADPH as reductant. The decrease in 465 nm absorption and the increase 
in absorption at 700 nm were extremely fast and more than 85% 
completed in the dead time of the instrument (1.3 ms). The rate constant is 
estimated at >2000 s"1. The observed rate is comparable with the rate of 
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the initial step, >300 s~', in the reduction of A. vinelandii lipoamide 
dehydrogenase by NADH (Benen et al, 1992) and shows that this step is 
not rate-limiting. From the spectral changes involved and in analogy with 
other disulfide reductases (Benen et al, 1991, Veeger and Massey, 1963, 
Lennon and Williams, 1997) it is concluded that this step represents the 
formation of a charge-transfer complex between the reduced flavin and 
NADP+. A charge-transfer complex between oxidized flavin and NADPH 
with similar spectral characteristics (Huber and Brandt, 1980, Lennon and 
Williams, 1997) seems unlikely in view of the short lifetime of this 
intermediate and the absence of intermediate phases in the stopped-flow 
traces. However, we cannot exclude that the 700 nm absorption is due to a 
mixture of both species, which are in rapid equilibrium. This rapid phase 
was followed by a much slower phase in which the flavin absorption at 
465 nm increased and the 700 nm absorption decreased. Presumably this 
step represents the transfer of electrons from the flavin to the redox-active 
disulfide. Similar, but faster changes in the absorption spectra have been 
observed by Benen et al (1992) with A. vinelandii lipoamide 
dehydrogenase in which the active site His has been replaced by a Ser. 
The slower phase of the reaction could be followed more accurately with 
the diode array spectrophotometer (Fig. 3A). The enzyme was mixed with 
4.2 molar equivalents of NADPH and spectra were immediately recorded. 
After 30 s the initially formed charge-transfer complex between reduced 
flavin and NADP+ can still be observed absorbing at wavelengths beyond 
800 nm, mixed with the charge-transfer complex between the oxidized 
flavin and a thiolate of the reduced disulfide bridge, as indicated by the 
blue shifted 450 nm absorption and the 540 nm absorption. The decrease 
in NADPH absorption (see inset) indicated the transfer of 1.57 electrons 
per FAD to the enzyme. After 38 min the 700 nm absorption band had 
almost disappeared and the flavin absorption started to decrease slowly 
over a period of hours, together with a further decrease in NADPH 
absorption. After 24 hr a small amount of free semiquinone was present in 
the mixture, indicated by an increase in absorption at 580 nm. Further 
reduction is very difficult to achieve. Even with a forty-fold molar excess 
of NADPH only a marginal further reduction is achieved. Only in the 
presence of arsenite the flavin is slowly further reduced, but not 
completely (Westphal et al, 1997). 
Purification and characterization of EPXB 57 
U 
C ffl 
-Q 
O 
W 
< 
0 . 1 5 -
. 
0 . 1 0 -
-
-
0 . 0 5 -
0.00 —[ 
V 
i i 
. ' • " • • . 
/ \ 
T—r | T™I 
p, 
i ; 
i; 
i; 
i; 
i; 
\ \'5 
\ V 
1 1 1 1 
If 
/"\ \ 
\\ \ 
\\ 
s\ \ \ 
V \ \ 
A 
300 400 500 600 700 
Wavelength (nm) 
0 . 1 5 -
0.10 
O 
c 
IS 
J3 
< 
0.05 
0.00 | i i i i i i i i i | i i i i i i i i i | i i i i 
300 400 500 600 
Wavelength (nm) 
Fig. 3. Anaerobic reduction of component II. A, reduction with NADPH in buffer A. (- -)The 
cuvette contained 19.8 nmoles (FAD) of oxidized component II in 1 ml., ( ) 30 s after addition 
of 42 nmoles NADPH, (-.-.-.-.-) after 38 min, ( ) after 10 h. B, reduction with sodium 
dithionite. ( ). The cuvette contained 12.3 nmoles (FAD) of oxidized component II in 1 ml, 
( ) 5 min after addition of 200 nmoles sodium dithionite, (—) immediately after addition of 
7.5 nmoles NADP+. 
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Fig. 4. Spectra of component II upon photoreduction with 5-deaza-riboflavin. The cuvette 
contained 50 mM EPPS pH 8.5, 10% glycerol, 15 mM EDTA, 1.5 uM 5-deaza-riboflavin and 40 
uM component II. The lines represent stable spectra taken after different times of 
photoreduction. ( ) No photoreduction; ( ) 20 s of photoreduction; ( ) 40 s of 
photoreduction and ( ) 80 s of photoreduction. 
Anaerobic reduction by dithionite was also slow and incomplete. Even 
with a 32-fold molar excess a small amount of semiquinone remained 
present (Fig. 3B). The subsequent addition of 1.2 equivalent NADP+ 
yielded a mixture of the oxidized enzyme and semiquinone. 
In Fig. 4 photoreduction of the enzyme in the presence of deaza 
riboflavine and EDTA is shown. Directly after irradiation the flavin is 
reduced, rapidly forming the flavin semiquinone as indicated by a 
decrease in absorption at 465 nm and an increase at 570 nm. Directly after 
reduction the flavin slowly reoxidizes (k = 0.016 s"1) while passing the 
electrons to the disulfide forming a stable charge-transfer complex, 
characterized by absorption at 450 nm and 530 nm and a decrease of the 
570 nm absorption. Each spectrum was taken after no further changes 
took place. Different stages of the reduction process of component II can 
be clearly seen in Fig. 4. 
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(i). The transfer of electrons from the flavin to the disulfide can be seen in 
the FAD spectrum after 20 seconds of photoreduction. There is no 
change in the absorption of the flavin (465 nm) but there is a small shift 
of the maximum to a lower wavelength, furthermore, in the range of 
520-600 nm the absorption increases, indicating the formation of the 
flavin-thiolate charge-transfer complex (Williams, 1992). 
(ii). After a longer period of photoreduction the semiquinone forms, 
characterized by a broad band centered at 610 nm (Mtiller et al. 1972). 
(iii). No further reduction to the EH4 species could be achieved, even after 
prolonged irradiation. 
STEADY-STATE KINETIC PROPERTIES OF COMPONENT II 
Because the physiological substrate of the component II protein is not 
known the artificial substrate 1,3-propanedithiol was used to study the 
steady-state kinetics of the enzyme. Nbs2 could not be used for this study 
because at higher concentrations of the compound substrate inhibition was 
observed (data not shown). 
In Fig. 5 Lineweaver-Burk plots showing the enzyme activity with 
varying 1,3-propanedithiol and fixed NADP+ concentrations (Fig. 5A) and 
varying NADP+ at fixed 1,3-propanedithiol concentrations (Fig. 5B) 
respectively are shown. The convergent lines demonstrate that component 
II of Xanthobacter Py2 at least with the substrate used is not functioning 
according to a ping-pong mechanism but to a ternary complex mechanism 
in the direction of NADP+ reduction. From secondary double reciprocal 
plots (see inset) the V and Km values were determined: V = 0.65 U/mg, 
kcat = 0.62 s"1, Km 1,3-propanedithiol = 0.63 mM, Km NADP+ = 11.6 
U.M. 
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Fig. 5. Steady-state kinetics of the reaction of component II with 1,3-propanedithiol. The 
activities were measured in EPPS-buffer pH 8.5 (for details see the Materials and Methods 
section). A. Lineweaver-Burk plot of the reaction with [1,3-propanedithiol] varied and [NADP+] 
fixed. (•) 30 M.M; ( • ) 150 |a.M; (A) 300 ^M and (•) 500 ^M NADP+. (B) Lineweaver-Burk plot of 
the reaction with [NADP+] varied and [1,3-propanedithiol] fixed. (•) 0.4 mM and (•) 4 mM 1,3-
propanedithiol. 
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Discussion 
Component II of the epoxide carboxylase pathway has been purified and 
shown to be a homodimeric protein of about 117 kDa. The protein 
contains a tightly, but non-covalently, bound FAD and a redox active 
disulfide bridge and is NADP dependent. 
The absorption spectra of the oxidized enzyme and some intermediates are 
typical for pyridine nucleotide disulfide oxidoreductases. The main 
difference with other disulfide oxidoreductases is the very slow transfer of 
electrons from the flavin to the disulfide bridge. This may be caused by 
the lack of the active site His-Glu diad, as inferred from comparison of the 
sequence with that of other disulfide reductases (Swaving et al, 1996). 
Mutants of dihydrolipoamide dehydrogenase from A. vinelandii (Benen et 
al., 1991, 1992), E. coli (Williams et al, 1989) and human (Kim and 
Patel, 1992), where the C-terminal active site histidine has been replaced 
by other residues, have an approximately 200-fold lower activity towards 
disulfides, comparable to component II in its activity to disulfides. The 
role of the active site His in lipoamide dehydrogenase is not only 
restricted to the activation of the dithiol substrate but also results in the 
stabilization of the nascent thiolates of the disulfide bridge. In the H450S 
mutant the rate of reduction of the flavin by NADH is unimpaired, but the 
rate of transfer of electrons from FAD to the disulfide bridge is very slow 
compared to the wild type enzyme (Benen et al, 1992). A similar situation 
seems to apply to component II. As this rate is independent of the type of 
electron acceptor used, this observation also shows that the low activity of 
component II is not caused by the use of artificial substrates such as 
dithiothreitol and 1,3-propanedifhiol, but is an inherent property of this 
enzyme. 
Another exceptional property of the enzyme is that full reduction to the 
EH4 state is very difficult to achieve. Obviously the redox potential of the 
EH2/EH4 couple is very low and component II shuttles apparently between 
the oxidized form (Eox) and the two electron reduced (EH2) state. 
Therefore, despite the common lack of the active site His, the enzyme 
differs in this respect from mercuric reductase (Distefano et al., 1989). 
The enzyme operates in the "reverse" reaction, dithiol —¥ NADP+, by a 
ternary complex mechanism. Such a mechanism is also observed in 
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glutathione reductase in the reverse direction, GSH —» NADP+ 
(Mannervik, 1973, Rakauskiene et al, 1989) or in the E. coli mutant 
Y177S in the physiological direction (Berry et al, 1989). Apparently in all 
these cases, the slow reduction of the flavin by one of the substrates 
allows the enzyme-substrate binary complex to bind the other substrate. 
Due to the lack of an oxidized dithiol substrate the reaction could not be 
studied in the forward reaction. 
The study of component II is seriously hindered by the lack of knowledge 
on the true physiological substrate. At this moment we cannot exclude the 
possibility that the enzyme is activated by interaction with another 
protein. Of interest in this respect is the nature of the orfl gene product 
which contains rubredoxin and thioredoxin like CxxC motifs (Swaving et 
al., 1995). None of the other orf s contains such motifs. On the other hand 
the component II activity towards disulfides and the amount of the protein 
present (at least 15% of the total soluble protein) is probably enough to 
keep up with the epoxyalkane degradation activity, approximately 0.02 
U/mg, found in crude extracts of Xanthobacter Py2 (Weijers et al., 1995). 
Another possible substrate for component II is the epoxyalkanes. Based 
on inhibition by sulfhydryl blocking reagents (Weijers et al, 1995) it is 
suggested that epoxyalkanes are reduced by (binding to) a redox active 
disulfide (Fig. 1). We tested this option with component II, but no activity 
was found (Table 2). Furthermore, a possible interaction of component II 
with epoxypropane was studied, looking at changes in the FAD spectrum 
of component II (both oxidized or reduced) after addition of 
epoxypropane. No indication of such an interaction was found (data not 
shown). These data are in agreement with the findings of Allen & Ensign 
(1997a,b) who propose component I as the epoxide binding enzyme on the 
basis of inhibition by substrate analogs. Whether the product of the 
reaction catalyzed by component I is bound to a disulfide, e.g. the orf2-
encoded protein or component II, as proposed by Allen and Ensign 
(1997a) or to another factor during the reaction cycle, is central to the role 
of component II in epoxide degradation and requires further investigation. 
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6 
Speculations on the mechanism 
of epoxyalkane degradation in 
Xanthobacter Py2 
Initially, only little information was available concerning the degradation 
of epoxyalkanes by the Xanthobacter Py2. Ketones were thought to be the 
degradation product of epoxyalkane conversion and NAD and an 
unknown low molecular mass fraction were found to be necessary for 
epoxyalkane conversion in crude extracts of propene grown Xanthobacter 
Py2. 
Fig. 1. The pathway 
as proposed initially 
for degradation of 
epoxyalkanes to 
ketones involving a 
reductase and a 
secondary alcohol 
dehydrogenase 
(ADH). 
O 
H—C-C-CH 3 I I 3 
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H OH 
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Based on these data a degradation pathway for epoxyalkanes was 
proposed. The epoxyalkane was thought to be reduced first to a secondary 
alcohol, which in turn was oxidized by an alcohol dehydrogenase to a 
ketone using NAD as cofactor (Fig. 1). This view on the degradation 
implied that the key protein in the degradation of epoxyalkanes was the 
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reductase involved in the conversion of epoxyalkanes to an alcohol. 
Although later the degradation of epoxyalkanes by Xanthobacter Py2 
showed to be more complex as described in this thesis, the basic thought 
of epoxides first being reduced and then oxidized however has not 
changed. 
Weijers et al. (1995) proposed a more detailed, mechanism. Based on their 
finding that DTT could replace the unknown cofactor and the inhibiting 
effect of NEM (a sulfhydryl-binding compound) a mechanism involving 
binding of the epoxide substrate to a disulfide bridge (Fig. 2A) was 
proposed. In the literature several other attempts have been presented to 
include new findings in the degradation pathway of epoxides. These 
mechanisms are all based on the mechanism originally proposed by 
Weijers et al. (1995). The common theme in all of these models is that the 
substrate binds to a thiolate of a redoxactive disulfide bridge (Chan Kwo 
Chion & Leak, (1996), Fig.2B; and Allen & Ensign, (1997a), Fig. 2C). 
Very recently, a paper was published by Allen and Ensign (1997b) 
concerning the purification of enzymes involved in epoxide degradation. 
This paper shows that four proteins are involved in the degradation of 1,2-
epoxypropane. These proteins are encoded (partially) on the 4.8 kb 
subclone found to complement mutants defective in epoxide degradation 
(Chapter 3). The proteins are ORF1 (component I), ORF3 (component II), 
ORF4 (component III) and ORF5 (component IV). Allen and Ensign 
showed that for every epoxide carboxylated, one NADPH and one NAD 
are needed. 
In this chapter, these proteins together with the or/2-encoded protein and 
their possible role in the degradation epoxides by the Xanthobacter Py2 
are discussed. 
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Fig. 2. Mechanisms of the degradation of 1,2-epoxypropane as proposed in literature. The first 
proposal came from Weijers et al. (1995). They proposed the conversion of 1,2-epoxypropane 
to acetone, involving opening of the epoxide ring by binding of the epoxide to a disulfide bridge 
(A). The product is released from the disulfide bridge after oxidation of the hydroxy-group. Allen 
and Ensign (1997) propose almost the same mechanism, but included a carboxylation step into 
the release of the product from the disulfide bridge (C). Chan Kwo Chion and Leak (1996) 
suggested a different approach. After binding of the epoxide to the disulfide bridge, the C1 is 
activated by either the action of a base B: (B1) of the release of the disulfide bridge (B2) so it 
can be carboxylated to a 13-keto acid. 
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THE PROTEINS 
Component I is the substrate binding protein 
Only little homology is found of the component I protein with other 
proteins listed in the SwissProt protein database. However, there is a small 
but significant homology with cobalamine-independent methionine 
synthase (METE, E.C. 2.1.1.14). This enzyme catalyzes the transfer of a 
methyl group from methyltetrahydrofolate to homocysteine forming 
methionine. Only recently it was shown that the methionine synthase is a 
zinc containing metalloprotein (Gonzalez et al., 1996) Furthermore, it was 
shown that the conserved C-terminal cysteine is involved in binding the 
metal (Gonzalez et al., 1996). In component I this cysteine and 
surrounding amino acids are very well conserved, which might indicate 
binding of a zinc atom to component I (Table 1). Zinc (a strong Lewis 
acid) is known to be an excellent cofactor for substrate binding and 
activation of a Lewis base (e.g. an oxygen group). 
Table 1. The C-terminal part of component I is aligned to the C-terminal parts of METE 
proteins using the ClustalW program. Similar amino acids are shown in bold, identical amino 
acids are also underlined. The zinc-binding cysteine is double underlined. 
Enzyme Amino acid sequence 
Component I IRRLLEIVPADRLGVTTDCGLILLQRYIAQDKLHALVEGTKIVRAELAKAKQAA 
METE_YEAST ISTILKSYPAEKFWVMPDCGLKTRGWEETRLSLTHMVEARKYFREQYKN 
METE_ECOLI LKKAAKRIPAERLWVMPDCGI.KTRGWPETRAALANMVQAAQNLRRG 
METE_HAEIN LRKALNVIPKERLWVNPDCGLKTRGWTETIDQLKVMVDVTKKLRAELA 
Allen & Ensign (1997a) showed methylepoxypropane to be an inactivator 
of epoxide degradation, probably acting by binding irreversibly to a 
substrate-binding protein(s). Using this property they were able to purify 
component I by complementing methylepoxypropane treated extracts with 
component I containing fractions (Allen & Ensign, 1997b). Therefore, the 
protein seems to be the epoxide-binding component. Component I is a 
hexameric protein and was shown, as discussed before, to contain 0.83 
mole of zinc per mole of subunit component I. 
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THE SUBSTRATE OF COMPONENT II IS UNKNOWN 
The component II protein is discussed extensively in the preceding 
chapters. The homodimeric protein is essential for epoxide degradation. 
The protein is strictly NADP(H) dependent, however, it is not clear what 
the component II protein reduces. 
In the family of pyridine nucleotide-disulfide oxidoreductases there are 
some examples of enzymes using a "charge transporter" for the transport 
of electrons from or to a recipient (e.g. thioredoxin, glutaredoxin, and 
rubredoxin reductases). In Chapter 5 it was speculated that another protein 
is the substrate for component II, and the protein encoded by orfl was 
proposed to be a possible candidate. Although, Allen and Ensign (1997b) 
did not find the or/2-encoded protein to be involved in epoxide 
carboxylation, it is a very interesting protein and will therefore be 
discussed here. 
Orf2-encoded protein maybe a thioredoxin like protein 
The orf2-encoded protein is a hypothetical protein of only 66 amino acids. 
Four of the eight cysteines found on the peptide are arranged in such a 
way that they form two Cys-X-X-Cys disulfide motives which seem to 
resemble the redox active disulfide found in thioredoxin, or the metal 
binding disulfide motive found in rubredoxin (Table 2). Both these small 
peptides are involved in electron transport from the corresponding 
reductase to the target protein, thioredoxin via the redox active disulfide, 
and rubredoxin using a Fe-S center. Rubredoxin and thioredoxin 
reductases are both members of the same family of pyridine nucleotide-
disulfide reductases as the component II protein. It is therefore not 
unlikely if the component II passes on its electrons to this small peptide 
(Chapter 5), which in turn passes them on to either an epoxide degrading 
protein or to (a derivative of) the epoxide. 
Table 2. Comparison of the two disulfide motives found in the hypothetical or/2-encoded 
protein of Xanthobacter Py2 to thioredoxins and rubredoxins. 
ORF2 
RUBR_CLOST 
RUB2_PSEOL 
THIO_ECOLI 
THI1_YEAST 
1st disulfide motive 
TIKCPDCGHV 
DWVCPDCGVG 
KWICITCGHI 
2nd disulfide motive 
VWVCSQCKSE 
DWVCPDCGVG 
KWICITCGHI 
AEWCGPCKMI 
ATWCGPCKMI 
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Component III 
Component IV 
DHG2_BACME 
FABG_BACSU 
MSRVAIVTGASSGNGIAIATRFLARGDRVAALDLSAETLEETARTHWHAYADKVL 
MLDAEVIAITGGAAGIGLAVAHAAIRAGARVALIDRDGACAQRAAAEFGAAAWG 
MYTDLKDKVWVTGGSKGLGRAMAVRFGQEQSKWVNYRSNEEEALEVKKEIEEAGGQAI 
MLNDKTAIVTGASRGIGRSIALALAKSGANVWNYSGNEAKANEWDEIKSMGRKAI 
Component III 
Component IV 
DHG2_BACME 
FABG_BACSU 
RVRADVADEGDVNAAIAATMEQFGAIDVLVNNAGITGNSEAGVLHTTPVEQFDKVMAVNV 
-VGADVTDEAAITAAMAGAQRALGPLTGLVNNAGIAG FGSVHATEVETWSRIMAVNV 
IVRGDVTKEEDWNLVETAVKEFGSLDVMINNAGVEN PVPSHELSLENWNQVIDTNL 
AVKADVSNPEDVQNMIKETLSVFSTIDILVNNAGITR DNLIMRMKEDEWDDVININL 
Component III RGIFLGCRAVLPHMLL-QGAGVIVNIASVASLVAFPGRSAYTTSKGAVLQLTKSVAVDYA 
Component IV TGTFLASKAALFGMLE-RGRGAIVNFGSVAGLVGIPTMAAYCAAKGAWNLTRQMAADYS 
DHG2_BACME TGAFLGSREAIKYFVENDIKGOTI^SSVHEMIPWPLFVHYAASKGGMKIJITETLALEYA 
FABG_BACSU KGVFNCTKAVTRQMMK-QRSGRIINVSSIVGVSGNPGQANYVAAKAGVIGLTKSSAKELA 
Component III GSGIRCNAVCPGMIETPMTQWRLD QPELKDQVLARIPQKEIGTAAQVADAVMFLAG 
Component IV GRGIRVNWCPGTVAGTDMGRQLLGTDCDPELEARRLAKYPMGRFGTPEDIAEAAVFLLS 
DHG2_BACME PKGIRVNNIGPGAIDTPINAEKFA DPEQRADVESMIPMGYIGKPEEIASVAAFLAS 
FABG_BACSU SRNITVNAIAPGFISTDMTDKLAK DVQDEMLKQIPLARFGEPSDVSSWTFLAS 
* * * * * * ** 
Component III EDATYVNGAALVMDGAYTAI 
Component IV TKAAFVTGSVLAVDGGMTAI 
DHG2_BACME SQASYVTGITLFADGGMTKYPSFQAGRG 
FABG_BACSU EGARYMTGQTLHIDGGMVM 
* * • * * 
Fig. 3. Alignment of component III, component IV, the glucose 1-dehydrogenase of 
Bacillus megaterium (DHG2_BACME) and Bacillus subtilis 3-oxoacyl [acyl-carrier-
protein] (FABG_BACSU) reductase, showing the high degree of identity (*) and 
homology (.).The conserved active site tyrosine (Y) is indicated in bold. 
Component III and component IV are similar to short chain alcohol 
dehydrogenases 
Fig. 3 clearly shows that both the components III and IV are member of 
the short chain alcohol dehydrogenases. The highest similarity is found 
with each other indicating that they may originate from gene duplication. 
Short chain alcohol dehydrogenases are non-metal proteins that act 
through base-acid catalysis. 
Allen and Ensign (1997b) showed that both these proteins are involved in 
the carboxylation of epoxyalkanes. The proteins are dimers, but curiously, 
the two subunits of component III are different in size. From mass-
spectrometry it was concluded the molecular weights of the subunits are 
26124 Da and 26025 Da. It is not clear what causes this difference of 99 
Da. 
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Different steps in epoxide carboxylation 
For the conversion of epoxyalkanes into 6-keto acids at least three distinct 
steps can be identified, an oxidation and a reduction step which follows 
from the involvement of NAD+ and NADPH, and a carboxylation step. 
However, there are three different oxidoreductases involved in epoxide 
carboxylation, component II and the two alcohol dehydrogenases, 
component III and IV. There are several explanations for this surplus of 
oxidoreductases: (i) one of the oxidoreductases is not doing a redox 
reaction, (ii) there is an additional reduction/oxidation step, (iii) one of the 
oxidoreductases is reducing/oxidizing an other oxidoreductase protein. 
The data from Allen and Ensign (1997b) concerning the use of the suicide-
substrate methylepoxypropane clearly demonstrates the epoxide ring is 
opened while it is in contact with component I. Probably, the zinc 
polarizes the epoxide ring, making the carbon more susceptible for attack. 
The component II is strictly NADPH-dependent; therefore this protein is 
involved in the reduction step. As a consequence one of the alcohol 
dehydrogenases (component III or component IV) is involved in the 
oxidation step using NAD . 
There is no clear understanding on which proteins are responsible for the 
carboxylation step. 
A DEGRADATION MECHANISM OF 1,2-EPOXYPROPANE BYXANTHOBACTER PY2 
There are now four different enzymes isolated from which it is known that 
they are involved in the conversion of epoxides to 6-keto acids. It is, 
however, not clear if these enzymes form a multi enzyme complex or if 
they act independently on the substrate. In favor of a multi enzyme 
complex is the fact that no intermediates of the conversion of epoxides to 
B-keto acids have been detected. On the other hand, no multi enzyme 
complex has been detected sofar. 
In the case of a multi enzyme complex the substrate is often bound to a 
flexible chain or carrier protein, so it is able to traverse to the different 
proteins to undergo specific reactions. Based on proteins involved in 
epoxide degradation and the carboxylation reaction there maybe some 
similarities to three different "enzyme carriers" from known multi enzyme 
complexes. First a flexible chain containing lipoamide used in the 
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pyruvate dehydrogenase complex. Second, an ACP (Acyl Carrier Protein) 
like protein used in the biosynthesis of fatty acids. And third a biotin 
linker domain; biotin is often found to be a carrier for CO2 in ATP-
dependent carboxylation reactions. However, no similarities to these 
carriers could be identified on the proteins involved in the epoxide 
degradation on the primary amino acid sequence level. 
Alternatively, a protein that on basis of its amino acid sequence could be a 
candidate for a substrate carrier, is the orf2-encoded protein. Allen and 
Ensign (1997b) however, did not find this protein in their preparations. 
This protein however is very small (7.3 kDa) and consequently hard to 
detect. It can therefore not be excluded that this protein may still play a 
role in the degradation of epoxides. Especially, because this or/2 is located 
in the same operon-like structure as the genes encoding component I-IV. 
In Fig. 4 a possible degradation mechanism is presented on basis of the 
information available. The mechanism involves a combined action of zinc 
bound to component I, and an unidentified reduced redox active disulfide 
bridge, which can be the or/2-encoded protein. The zinc bound to 
component I polarizes the epoxide ring, making the carbon more 
susceptible for attack by one of the -SH groups of the disulfide bridge. 
From a chemical point of view, a ketone is more easily carboxylated than 
an alcohol, so the substrate is first oxidized to a ketone by one or both 
short-chain alcohol dehydrogenase (component III or IV). If no CO2 is 
present, ketones are released from the protein upon oxidation of the 6-
hydroxy group. If, however, CO2 is present in the reaction the substrate is 
carboxylated to a 8-keto acid and is released from the disulfide bridge. 
Possibly, the other alcohol dehydrogenase (component III or IV) is 
involved in this carboxylation reaction. 
Sofar, only parts of the puzzle have been studied in detail giving new 
insights on the mechanism and cofactor use of epoxide degradation in 
Xanthobacter Py2. The main problem for a detailed study on the 
enzymology of the epoxyalkane degradation was, and still is, the low 
specific activity. Using genetic and biochemical techniques to investigate 
the involvement of each of the proteins, is probably the most promising 
way to obtain more information on the mechanism of this new and 
interesting type of degradation of epoxyalkanes as found in Xanthobacter 
Py2. 
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Summary 
Due to the differences in biological activity of the enantiomers of racemic 
compounds, the use of enantiomerically pure drugs and agrochemicals is 
very much encouraged. The availability of optically pure synthons for the 
production of drugs is, therefor, of the utmost importance for the 
pharmaceutical industry. 
A very versatile intermediate in organic synthesis is the epoxide group. 
Epoxides very easily undergo stereospecific ring-opening reactions and 
are, therefor, very useful to function when available in an 
enantiomerically pure form as synthons in the production of optically pure 
drugs. 
In recent years, a great deal of research has been devoted to the 
development of a biocatalytic method to produces these optically pure 
epoxides. A very promising method for this is the enantioselective 
degradation of racemic epoxides (Chapter 2). Although, such a method 
has a yield of at most 50% it still can be an interesting option, because, 
racemic epoxides are relatively cheap. A very nice example of 
enantioselective degradation is found in the bacterium Xanthobacter Py2 
which is able to enantioselectively degrade a racemic mixture of 2,3-
epoxyalkanes. The 2S-enantiomers are degraded completely, resulting in 
optically pure 2R-epoxyalkanes. 
At the start of the research done on the degradation of epoxyalkanes by 
Xanthobacter Py2 described in this thesis, only little information was 
available on how degradation proceeds. From experiments performed in 
crude extracts of propene grown Xanthobacter Py2 it was thought that 
ketones were the product of epoxyalkane degradation (later it was shown 
epoxyalkanes are carboxylated to B-keto acids). Furthermore, it was 
concluded that the degradation was dependent on NAD and an unknown 
low molecular mass compound, which could be replaced by dithiol 
compounds such as dithiothreitol (DTT). 
To study the degradation of epoxyalkanes by Xanthobacter Py2 in more 
detail it was decided to do complementation studies using Xanthobacter 
Py2 mutants devoid of epoxyalkane-degrading activity (Chapter 3). 
Several cosmids were found complementing restoring the ability of the 
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mutants to grow on epoxides. One of these cosmids, pEP9 was conjugated 
into Xanthobacter autotrophicus GJ10. This strain is not able to grow on 
1,2-epoxypropane nor able to degrade the compound. In crude extracts of 
Xanthobacter autotrophicus GJ10 complemented with the pEP9, however, 
epoxyalkane-degrading activity was demonstrated, but only after addition 
of the LMF or DTT, indicating the right genes were cloned. 
Subcloning revealed a 4.8 kb fragment able to complement the mutation. 
This fragment was sequenced and found to contain four open reading 
frames which code for proteins of 41690, 7388, 57315 and 26111 Da, 
respectively. A homology search using the Swiss-Prot protein bank did 
reveal little or no homology for the first two ORFs. For ORF4, 
homologies were found with short-chain alcohol dehydrogenases like 3-
oxoacyl reductase and glucose 1-dehydrogenase. Interestingly, ORF3 
showed significant homology with pyridine nucleotide-disulfide 
oxidoreductases like mercury (II) reductase, glutathione reductase and 
with dihydrolipoamide dehydrogenase. 
In Chapter 4 and Chapter 5, the protein encoded by this third open reading 
frame was investigated in more detail. All consensus primary structures of 
pyridine nucleotide-disulfide oxidoreductase are present on the ORF3 
amino acid sequence but the C-terminal active site. Furthermore, from the 
amino acid sequence it was deduced that the nucleotide binding site of 
NAD(P) showed more resemblance with NADP-dependent proteins then 
with NAD-dependent proteins, indicating that the ORF3 is NADP-
dependent. Using this information the involvement of NADP was tested in 
the conversion of epoxyalkane in dialyzed crude extracts of propene 
grown Xanthobacter Py2. It was shown that NADPH and NAD could 
restore the epoxyalkane degradation, indicating that NADPH is in fact the 
low molecular mass fraction. The dithiols replacing the low molecular 
mass fraction are probably able to directly reduce the redox active 
disulfide bridge on the ORF3 protein. NADPH also reduces this disulfide 
bridge by passing on the electrons via a FAD, which is bound to the 
protein. 
The ORF3 protein was purified and shown to be involved in epoxyalkane 
degradation by fractionating crude extracts of propene grown 
Xanthobacter Py2 and complementing fractions without the ORF3 protein 
with the purified protein, thus restoring the epoxyalkane-degrading 
activity. 
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The purified 0RF3 protein in this stage called component II, was 
characterized (Chapter 5). The protein was shown to be a homodimeric 
protein, each subunit containing a tightly bound FAD. The spectral 
properties of the FAD were investigated and kinetic studies were 
performed to characterize the protein. 
Characterization on component II showed this protein to have common 
themes as well as distinct difference with other pyridine nucleotide-
disulfide oxidoreductases. This comparison gave no clear understanding 
on the substrate of the component II and its action in the degradation of 
epoxides. 
Because the component II protein is missing the C-terminal His-Glu dyad 
active site found in lipoamide dehydrogenases and glutathione reductases, 
the protein has a very low activity towards dithiols, therefore the substrate 
of component II may not even be a dithiol compound. 1,2-Epoxypropane 
is not a substrate for component II, nor is there any interaction with the 
compound. The involvement of an other (hypothetical) protein, ORF2 
ENCODED, is suggested. 
Finally, in Chapter 6, a possible mechanism for 1,2-epoxypropane 
degradation is discussed. 
Samenvatting 
De biologische activiteit van de verschillende enantiomeren van 
racemische mengsels van stoffen kan sterk verschillen. Om deze reden is 
het heel gunstig om van de optisch zuivere vorm van deze stoffen gebruik 
te maken voor b.v. geneesmiddelen of insecticiden. De beschikbaarheid 
van optisch zuivere grondstoffen (of intermediairen) is dan ook van het 
grootste belang voor de industrie. 
Een veelzijdige intermediair die veel gebruikt wordt in de organsiche 
synthese is de epoxide. De functionele groep van epoxide bestaat uit een 
driering van een zuurstof en twee koolstof atomen en kan vrij gemakkelijk 
stereospecifiek geopend worden. Deze eigenschap maakt het mogelijk dat 
de epoxide, als het tenminste verkrijgbaar is in een optisch zuivere vorm, 
als intermediar wordt gebruikt voor de productie van optisch zuivere 
geneesmiddelen. 
Omdat biokatalyse bij uitstek geschikt is voor de productie van optisch 
zuivere stoffen, is er de afgelopen jaren dan ook erg veel onderzoek 
gedaan naar de productie van optisch zuivere epoxiden. Een veel 
belovende methode hiervoor is de biologische enantiselectieve afbraak 
van racemische mengsels van epoxiden (hoofdstuk 2). Hoewel de 
opbrengst met deze methode maximaal 50% is, kan deze methode 
economisch gezien toch interessant zijn omdat de uitgangsstof, het 
racemisch mengsel van epoxiden, relatief goedkoop is ten opzichte van 
het product, de optisch zuivere epoxide. 
Een interessant voorbeeld van enantioselectieve afbraak wordt gevonden 
in de Xanthobacter Py2. Deze bacterie is in staat om een racemisch 
mengsel van 2,3-epoxyalkanen enantioselectief af te breken. Alleen 
2S-enantiomeren worden totaal afgebroken waardoor optisch zuivere 
2R-epoxyalkanen overblijven. 
In dit proefschrift wordt het onderzoek naar de afbraak van epoxyalkanen 
door de Xanthobacter Py2 beschreven. Tijdens de start van het onderzoek 
was er erg weinig bekend over hoe de Xanthobacter Py2 de epoxyalkanen 
afbreekt. Uit experimenten uitgevoerd met extracten van Xanthobacter 
Py2 werd in eerste instantie aangenomen dat ketonen het product waren 
van epoxyalkaan afbraak, later bleek echter dat epoxyalkanen 
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gecarboxyleerd werden tot 6-keto zuren. Verder was het bekend dat naast 
NAD nog een andere factor nodig was voor activiteit. Deze fractie kon 
vervangen worden door dithiolen zoals dithiothreitol (DTT). 
Om de afbraak van epoxyalkanen door de Xanthobacter Py2 beter te 
kunnen onderzoeken werd besloten om de genen betrokken bij de afbraak 
op te sporen en te analyseren (hoofdstuk 3). Om dit te bewerkstelligen 
werden mutanten van de Xantobacter Py2 gemaakt die niet meer op 1,2-
epoxypropaan konden groeien. Deze mutanten werden vervolgens 
gecomplementeerd met een genenbank van Xanthobacter Py2. Op deze 
manier werden verschillende plasmiden gevonden die in staat waren deze 
mutanten weer te laten groeien op 1,2-epoxypropaan. Een van deze 
plasmiden, de pEP9, werd naar de Xanthobacter autotrophics GJ10 
overgebracht. Deze stam is niet in staat om op 1,2-epoxypropaan te 
groeien. In een extract van Xanthobacter autotrophicus GJ10(pEP9) werd 
epoxyalkaan afbraak waargenomen. 
Van een 4.8 kb groot DNA-fragment waarop alle informatie ligt nodig om 
de mutanten te complementeren werd de basenvolgorde bepaald. Er 
bleken vier open reading frames (ORF's) op te liggen die coderen voor 
eitwitten van respectivelijk 41690, 7388, 57315 en 26111 Da. De eerste 
twee ORF's bleken geen homologie te hebben met eiwitten in de 
SwissProt-eiwit-databank. ORF4, daarentegen, vertoonde sterke 
homologie met 'short-chain'-alcoholdehydrogenases zoals 3-oxoacyl-
reductase en glucose-1-dehydrogenase. Opvallend was de homologie van 
ORF3 (component II) met pryridine-nucleotide-dusulfide oxidoreductases 
zoals kwik- en glutathion-reductase en dihydrolipoamide dehydrogenase. 
In de hoofdstukken 4 en 5 wordt het eiwit dat door het derde ORF 
(component II) codeerd in detail beschreven. Uit de aminozuurvolgorde 
blijkt dat alle consensus structuren van de pyridine-nucleotide-disulfide-
oxidoreductases, op de C-terminale active-site na, aanwezig zijn. Verder 
bleek dat de nucleotide-bindingsite van de NAD(P) meer overeenkomsten 
vertoonde met NADP-afhankelijke-enzymen dan met NAD-afhankelijke-
enzymen. Naar aanleiding van dit laatste werd de invloed van NADP op 
de epoxyalkaan afbraak onderzocht. Het bleek dat zowel NAD als 
NADPH nodig zijn voor de activiteit; de onbekende fractie, die vervangen 
kon worden door DTT bleek niet nodig. In hoofdstuk 4 wordt uitgelegd 
dat dithiolen (DTT) in staat zijn om de disulfidebrug van de component II-
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eiwit direct te reduceren, terwijl NADPH dat doet via een FAD groep die 
gebonden is aan het enzym. 
Het component II-eiwit bleek essentieel voor de epoxyalkaan afbraak. Dit 
werd aangetoond door het eiwit te zuiveren en toe te voegen aan 
gefractioneerd extracten van Xanthobacter Py2. De fractie waar het 
component II-eiwit uit was verwijderd, was niet actief, maar als hier 
gezuiverd component II aan werd toegevoegd werd de activiteit hersteld 
(hoofdstuk 4). 
Het component II-eiwit werd gezuiverd en nader onderzocht (hoofdstuk 
5). Het enzym is een dimeer, met aan elke groep een sterk gebonden FAD. 
Hoofdstuk 5 beschrijft de spectrale eigenschappen en de kinetiek van het 
enzym. Het component II-eiwit bleek zowel overeenkomsten als 
verschillen te vertonen met de andere leden van de familie van pyridine-
nucleotide-disulfide-oxidoreductases, maar het is niet duidelijk aan welke 
disulfide oxidoreductase het eitwit het meest verwant is. Ook werd het 
niet duidelijk wat nu precies het substraat van component II is en wat de 
rol is die het speelt bij de afbraak van epoxiden. Epoxypropaan is geen 
substraat voor het eiwit, en er is ook geen interactie van het eiwit met deze 
stof. In hoofdstuk 5 wordt gespeculeerd dat een ander eitwit het substraat 
van component II is. 
In Hoofdstuk 6 tenslotte, wordt een speculatief mechanisme voor de 
afbraak van epoxiden door de Xanthobacter Py2 besproken. 
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